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Impact Of Topical Antimicrobial Treatments On Skin Bacterial Communities
Abstract
Skin is our primary interface to the outside world, representing a diverse habitat with a multitude of folds,
invaginations, and appendages. While each of these structures is essential to host cutaneous function,
they also serve as unique ecological niches that can support an array of microbial inhabitants. Together,
these microorganisms constitute the skin microbiome, an assemblage of bacteria, fungi, and viruses with
the potential to influence cutaneous biology. While a number of studies have described the importance of
these residents to immune function and development, none to date have assessed their dynamics in
response to antimicrobial stress, nor the impact of these perturbations on host cutaneous defense.
Rather the majority of work in this regard has focused on a subset of microorganisms studied in isolation.
Herein, we present the impact of topical antibiotics and antiseptics on skin bacterial communities, and
describe their potential to shape cutaneous interactions. Using mice as a model system, we show that
antibiotics can elicit a distinct shift in skin inhabitants characterized by decreases in diversity and
domination by previously minor contributors. By contrast, we report a relatively modest impact of
antiseptics on skin bacteria, largely preserving inhabitant structure at the community-level. Despite these
differences, we show a significant decrease in Staphylococcus residents regardless of treatment, a
subset of inhabitants which we also found to influence colonization by the skin pathogen Staphylococcus
aureus. To determine the relevance of these findings in human systems, we further treated thirteen
subjects with antiseptics at the forearm and back. Similar to mouse experiments, we observed a relatively
minor effect of these treatments on bacterial inhabitants at the population-level. However, when
controlling for factors such as interindividual differences and body-site specificity, we observed a more
significant impact, governed in large part by decreases in lowly abundant members of the skin
microbiota. We also found bacterial identity to be a key contributor to this effect, with certain skin taxa
exhibiting more robust shifts than others. In all, these results underscore the ability of antimicrobial drugs
to alter skin bacterial residence, and outline the importance of these inhabitants to host cutaneous
defense.
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ABSTRACT

IMPACT OF TOPICAL ANTIMICROBIAL TREATMENTS ON
SKIN BACTERIAL COMMUNITIES
Adam Jason SanMiguel
Elizabeth Anne Grice, Ph.D.

Skin is our primary interface to the outside world, representing a diverse habitat
with a multitude of folds, invaginations, and appendages. While each of these
structures is essential to host cutaneous function, they also serve as unique
ecological niches that can support an array of microbial inhabitants. Together, these
microorganisms constitute the skin microbiome, an assemblage of bacteria, fungi,
and viruses with the potential to influence cutaneous biology. While a number of
studies have described the importance of these residents to immune function and
development, none to date have assessed their dynamics in response to
antimicrobial stress, nor the impact of these perturbations on host cutaneous
defense. Rather the majority of work in this regard has focused on a subset of
microorganisms studied in isolation. Herein, we present the impact of topical
antibiotics and antiseptics on skin bacterial communities, and describe their
potential to shape cutaneous interactions. Using mice as a model system, we show
that antibiotics can elicit a distinct shift in skin inhabitants characterized by
decreases in diversity and domination by previously minor contributors. By
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contrast, we report a relatively modest impact of antiseptics on skin bacteria, largely
preserving inhabitant structure at the community-level. Despite these differences,
we show a significant decrease in Staphylococcus residents regardless of treatment,
a subset of inhabitants which we also found to influence colonization by the skin
pathogen Staphylococcus aureus. To determine the relevance of these findings in
human systems, we further treated thirteen subjects with antiseptics at the forearm
and back. Similar to mouse experiments, we observed a relatively minor effect of
these treatments on bacterial inhabitants at the population-level. However, when
controlling for factors such as interindividual differences and body-site specificity,
we observed a more significant impact, governed in large part by decreases in lowly
abundant members of the skin microbiota. We also found bacterial identity to be a
key contributor to this effect, with certain skin taxa exhibiting more robust shifts
than others. In all, these results underscore the ability of antimicrobial drugs to alter
skin bacterial residence, and outline the importance of these inhabitants to host
cutaneous defense.
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Chapter 1 – Introduction to antimicrobial drugs and the skin
microbiome

1.1 Historical perspective
Studies of the skin microbiome have, throughout history, become inextricably linked
with a desire to remove said inhabitants. This is perhaps best exemplified by early
reports describing the utility of hygiene and antiseptics under Ignaz Semmelweis
and Joseph Lister in the mid-1800s1,2. These studies described the potential for
antibacterial compounds to reduce infection and improve surgical mortality rates, a
figure well above 10% in developed countries at the time3. While initially
controversial, antiseptic methods were ultimately accepted by the medical
community, and heralded as a proficient means to reduce the levels of skin bacterial
residents with the potential to cause disease4-7.

As time progressed, researchers built upon these studies with a focus on chemicals
displaying the greatest potential for skin sterilization8,9, hoping to improve upon the
findings of Semmelweis and Lister. Eventually, however, two factors became
increasingly apparent in the fight against infection. First, that no technique was
capable of complete and consistent sterilization of the skin10,11. And second, that
many of the surviving microorganisms were also known residents of the skin,
eliciting little detriment in the overall outcome of patients12,13. This newfound
understanding led to a fundamental shift in the field of skin bacteriology, and, paired
with the advent of narrow spectrum antibiotics, resulted in experiments focused on
1

the disruption of specific pathogenic microorganisms rather than sterilization of
entire cutaneous populations14,15.

Since this time, a wealth of literature has described the impact of antibiotics and
antiseptics on infectious bacteria, underscoring the importance of these drugs to
human health and disease16-18. However, this focus has also led to constraints in our
knowledge of resident bacterial response. Indeed, although antimicrobial drugs are
commonly applied directly to the skin, few studies have assessed their impact
beyond that of pathogenic microorganisms19. A reliance on culture-based systems
has further complicated this question, with a true survey of antimicrobial effects
being all but impossible without prior knowledge of resident growth
requirements20. This has resulted in an over-simplification of the field, and the
presumption that effects on easily cultured skin residents can be applied to other
cutaneous inhabitants21. No study to date has adequately verified this assertion,
however, leading to conflicting views amongst researchers and physicians alike.

1.2 New technologies to answer an old question
In light of these shortcomings, we and others have begun to apply less-biased
methods to the identification of skin bacterial residents. Specifically, the
introduction of sequencing-based technologies has enabled the study of nearly all
bacterial inhabitants, rather than limiting researchers to microorganisms with wellestablished, culture-based protocols22. These approaches also represent a more
high-throughput method for bacterial community identification, exhibiting a
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significant advance on previous strategies which required an abundance of selective
medias and agars to differentiate between inhabitants23.

Sequencing-based technologies generally fall within two broad categories: markerbased and whole genome24. As its name would suggest, marker-based methods rely
on specific genes found throughout the bacterial kingdom to describe community
membership. Ideally, these genes contain stretches of both conserved and
hypervariable sequences. This then allows for the design of primers to conserved
areas, and the use of nearby hypervariable regions to distinguish amongst
residents25,26. The best example of such markers is the 16S rRNA gene, found
ubiquitously in bacteria27. This gene contains nine hypervariable regions, each
representing the opportunity to resolve differences in bacterial membership under
a variety of conditions. We and others have described the utility of the V1-V3
hypervariable regions for human skin bacterial identification28. However, other
regions can also be helpful depending upon the environment to be sampled29.

Despite these advantages, marker-based analyses are not without limitations.
Specifically, species- and strain-level information can be difficult to extract when
comparing residents with high proportions of sequence homology. To compensate
for this restriction, whole genome shotgun sequencing is often employed to acquire
longer stretches of information30. While more expensive than marker-based
approaches, this technique allows for higher levels of resolution when attempting to
distinguish between closely related bacterial inhabitants31. This method is also
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useful in metagenomic analysis, a type of examination which describes both the
composition and functional potential of a given community32. Cost can still
represent a prohibitive variable when making multiple comparisons, however. As
such, both resolution and price must be weighed appropriately, prior to
investigation, to maximize the breadth and depth of one’s analyses.

1.3 Study outline and rationale
With this information in mind, we applied sequencing-based methods to more
completely evaluate the impact of topical antimicrobial drugs on skin bacterial
residence. As our experiments represent the first attempts at said endeavors,
marker-based 16S rRNA gene sequencing was employed for community analyses.
This enabled us to widen the breadth of our comparisons, and to assess the
longitudinal dynamics of skin residents in response to multiple treatment regimens.

To control for the greatest number of variables, we began our tests in the murine
model system. SKH-1 hairless mice were treated at the dorsum with a triple
antibiotic ointment (Bacitracin, Neomycin, and Polymyxin B) or the narrow
spectrum antibiotic Mupirocin. Samples were then collected longitudinally to assess
changes in the skin microbiota over time. Antibiotic treated mice were compared to
those receiving vehicle ointments to control for non-antibacterial effects. A separate
cohort was also treated with water or the common clinical antiseptics alcohol (80%
ethanol) and povidone-iodine (Betadine) to compare mechanistically distinct
antimicrobial interventions.

4

During these investigations, we observed a conserved ability of all treatments to
disrupt Staphylococcus skin residence. Because members of this genus have been
shown to influence colonization by the skin pathogen Staphylococcus aureus33,34, we
also used our system to interrogate the role of antimicrobial drugs in skin
colonization resistance. Colonization resistance represents a means for resident
species to defend a host against more pathogenic microorganisms35. Moreover, in
the gastrointestinal tract, antibiotic treatment has been shown to increase host
susceptibility to infection through alterations in resident communities36. We show
that the skin microbiota functions in a similar manner, with multiple Staphylococcus
residents representing potential S. aureus competitors at the skin surface.

As a validation of these experiments, our final assessment included an investigation
of antiseptics and human skin bacterial residents. Previous studies have defined
these inhabitants as exhibiting high levels of both inter- and intrapersonal
variability37,38. This includes a distinct stratification of communities by cutaneous
biogeograpy39. To account for these variables, thirteen subjects were treated
identically at the back and forearm, body sites with significant topographical
distinction40. In all, these studies enabled us to evaluate the resilience of human
bacterial residents at the population-level, and together with our murine
experiments, expound the importance of key variables to skin bacterial community
response.
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Chapter 2 - Interactions between host factors and the skin
microbiome

The contents of this chapter have been published as:
SanMiguel A, Grice EA. (2015) Interactions between host factors and the skin
microbiome. Cell Mol Life Sci. Apr;72(8):1499-515.

2.1 Abstract
The skin is colonized by an assemblage of microorganisms which, for the most part,
peacefully coexist with their hosts. In some cases, these communities also provide
vital functions to cutaneous health through the modulation of host factors. Recent
studies have illuminated the role of anatomical skin site, gender, age, and the
immune system in shaping the cutaneous ecosystem. Alterations to microbial
communities have also been associated with, and likely contribute to, a number of
cutaneous disorders. This review focuses on the host factors that shape and
maintain skin microbial communities, and the reciprocal role of microbes in
modulating skin immunity. A greater understanding of these interactions is critical
to elucidating the forces that shape cutaneous populations and their contributions
to skin homeostasis. This knowledge can also inform the tendency of perturbations
to predispose and/or bring about certain skin disorders.
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2.2 Introduction
The skin is our primary interface to the external environment, supporting the
growth of commensal microorganisms while impeding invasion by more pathogenic
species. Culture-independent techniques that employ sequencing of marker genes,
such as the bacterial-specific 16S ribosomal RNA (rRNA) gene, have begun to
elucidate the community characteristics of these cutaneous microorganisms. In
addition, these analyses have been used to inform elements of intrapersonal and
interpersonal variability, as well as longitudinal dynamics of skin microbial
communities. These studies have also led to investigations into the importance of
host-microbe interactions, and their ability to shape the identity and composition of
commensal relationships. This review will highlight these determinants as they
pertain to a number of host factors. It will also address the role of microbiome-host
interactions in certain skin disorders. While numerous microorganisms are thought
to colonize the skin surface, we will emphasize the contribution of bacterial and
fungal inhabitants. However, it is important to note that viruses, mites, and archaea
are all capable of influencing residential populations of the skin.

2.3 Cutaneous architecture and biochemistry
To fully appreciate the microbial diversity of the skin, one must first understand the
complex architecture and environment of this organ. As a critical barrier to the
outside world, human skin is essential for activities such as thermoregulation, gas
exchange, and hydration [1]. It also represents one of the body’s largest and most
exposed organs with approximately 1.8 m2 of total surface area. The biogeography
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of the skin includes a number of planes, folds, and invaginations, each capable of
maintaining a unique microenvironment. For this reason, microbial communities
above the cool, desiccating skin surface often differ greatly from those found within
shielded pores and follicles [2]. Different skin sites can also contribute to microbial
heterogeneity through the production of various lipid- and water-based solutions.
These determinants then work in concert with additional host factors and the
external environment to shape an individual’s core microbiome.

2.3.1 Skin strata
Human skin consists of two main layers: the epidermis and the dermis (Figure 1). As
the most superficial layer, the epidermis contributes the majority of barrier
functions while the dermis provides a structural framework made of fibrous and
connective tissues. Underlying these strata is a layer of subcutaneous fat, which is
critical for the protection of deeper tissues and bones.

As a continually self-renewing epithelium, the epidermis can be subdivided into four
main strata, characterized by cells at varying stages of development (Figure 1). The
bottommost layer, the stratum basale, contains a single layer of undifferentiated
stem cells that rest upon the epidermal basement membrane [3]. All keratinocytes
originate from these basal cells, and they are essential for the regeneration of
keratinocytes lost to terminal differentiation and desquamation [4]. During
asymmetric cell division, these progenitor cells produce a subset of daughter cells
that exit the cell cycle and separate from the basement membrane to form the
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stratum spinosum. In this layer, immature keratinocytes are characterized by
abundant calcium-dependent desmosomes, which promote intercellular adhesion
and resistance to mechanical stress [5]. As these cells continue to develop, they also
flatten and initiate the formation of lamellar bodies and keratin filaments to support
overall skin structure [5].

Upon further maturation, keratinocytes progress upwards to populate the stratum
granulosum, so-named for the presence of prominent keratohyalin granules. These
vesicles contain filaggrin, keratin filaments, loricrin, and involucrin – all necessary
components for the hydration and structure of mature epidermal tissue [5].
Keratinocytes of the stratum granulosum are also held together by a number of
extracellular tight junction proteins including claudins and occludins, which are
essential to epidermal barrier function [6]. During the terminal stages of
differentiation, cells of the granular layer compress and anucleate to form the
stratum corneum. At this stage, keratinocytes then become known as corneocytes
for their highly cornified cellular envelopes. These protein-enriched cells are also
held together by keratins, corneodesmosomes, and a lipid-enriched extracellular
matrix to provide a strong physical barrier that is resistant to mechanical stress, UV
damage, and permeation [7].

2.3.2 Appendages
In addition to these strata, the skin is also characterized by a number of appendages
that can extend beyond the epidermis into the dermis. These include sebaceous
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glands, hair follicles, and sweat glands. Sebaceous glands specialize in the secretion
of sebum, an oily, lipid-rich substance that provides skin flexibility and
waterproofing. Most sebaceous glands are also connected to hair follicles to form
pilosebaceous units that concentrate on the face and upper body [8]. Pilosebaceous
follicles support an array of niche-specific microorganisms that can thrive in anoxic
environments rich in sebum-derived lipids [9]. These lipids can then be metabolized
into free fatty acids by bacterial commensals, which contribute to the acidic pH of
the skin [10]. Importantly, while the number and distribution of sebaceous glands
remains relatively constant throughout life, their size and activity fluctuates widely
depending on age and hormone levels [8]. It is thus not surprising that puberty
marks a defining period in skin development characterized by the elevated
production of sebum and sebum-related products, as well as the subsequent growth
of lipophilic skin microbial inhabitants [11].

Sweat glands, another critical appendage of the epidermis, can be divided into two
major types: apocrine and eccrine. Like sebaceous glands, apocrine sweat glands
release oily secretions into upper hair follicles and are especially active during
puberty. Apocrine sweat is composed of a milieu of proteins, lipids and steroids
[12]. Apocrine glands are also more sparsely distributed, often localized to
especially pileous regions such as the axillae and perineum [12].

Eccrine sweat glands, in contrast, are widely distributed throughout the body with
high concentrations at the forehead, axillae, palms, and soles [13]. They are also the
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only gland with direct access to the skin surface, and as such, continuously bathe the
epidermis in a water- and salt-based sweat solution. These secretions are critical to
thermoregulation and hydration, and also contribute to the relatively acidic pH of
skin surfaces.

In all, the dissemination and activity of epidermal appendages provide essential
roles for the human body. By creating habitats with unique levels of moisture, pH
and nutrients, they also represent specialized niches that can promote the growth of
distinct microbial communities. This then contributes to the unique stratification of
bacterial populations at skin sites throughout the body.

2.4 Host factors and the skin microbiota
2.4.1 Topographical variability
The site-specificity of the skin microbiota has been borne out in multiple
experiments analyzing unique topographical locations of the skin (Figure 2). For
example, a study of 20 distinct body sites representing sebaceous, moist, and dry
physiological environments found that Propionibacterium and Staphylococcus
species dominated sebaceous skin sites including the face and upper body [14]. By
contrast Corynebacterium, β-Proteobacteria, and Staphylococcus were the major
genera at moist sites such as the axilla, antecubital fossae (inner elbow), and
popliteal fossae (inner knee). Dry sites including the forearm and buttock were
found to be more variable, supporting the growth of numerous phylotypes including
β-Proteobacteria, Corynebacterium, and Flavobacteriales.
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Upon more in-depth analyses, it was revealed that the sites richest in bacterial
operational taxonomic units (OTUs; a sequence-level proxy for designating species)
were often dry regions such as the forearm, while sebaceous sites including the
upper back and retroauricular crease (behind the ear) were home to fewer bacterial
phylotypes. In addition, sebaceous regions were consistently lower in bacterial
evenness as measured by the relative distribution of sequences among OTUs.
Interpersonal variation (differences between individuals) was found to be greater
than intrapersonal variation (differences within individuals) over time. This
suggests that individuality and body site physiology are both strong determinants of
bacterial community membership and structure.

Similarly to above, Costello et al. observed that temporal intrapersonal variability
was less pronounced than interpersonal variability between individuals [15]. These
studies also confirmed that spatial intrapersonal variability (e.g. variability in
microbiomes of distinct body sites such as forehead, arm, and umbilicus) was even
greater than interpersonal variability at the same skin site. As such, although
individual microbial populations of the skin are often more similar to themselves in
regard to symmetry and time, these likenesses appear to breakdown when
comparing separate biogeographic regions.

In accordance with Grice et al., this group also found high levels of
Propionibacterium at sebaceous sites on the face, and greater diversity at areas such
as the popliteal fossa, forearm, and palm. Moreover, it was shown that the variation
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of these sites remained relatively constant over time, as the palm and forearm were
both consistently more diverse than the forehead at four separate collection
periods.

The influence of body site in regard to overall community structure was also tested
by inoculating bacteria from foreign sites onto new areas of the skin. These studies
observed a relative flexibility in forearm community membership, while the
forehead microbiota rapidly returned to a population resembling its native state.
This suggests that host factors may vary in their ability to promote bacterial
colonization, especially at sebaceous sites with strong environmental biases.

Whereas these studies sought to compare multiple body sites, additional research
has focused on individual skin regions. These studies largely complement one
another, providing greater insight into the contribution of topography to skin
microbial communities. For example, studies performed on the human forearm have
illustrated relatively high degrees of bacterial diversity, although this population is
consistently dominated by Propionibacterium, Corynebacterium, Staphylococcus,
Streptococcus, and Acinetobacter [14-17]. While these major taxa appear throughout
the literature, however, it appears that their relative contributions to the forearm
community can fluctuate greatly.

The same can be said of the palmar region, which is frequently exposed to new
surfaces and environments - while major phylotypes such as Propionibacterium,
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Streptococcaceae, and Staphylococcaceae are consistently observed, a great amount
of variability exists in regard to their absolute numbers and proportions
[14,15,18,19]. Thus it appears that certain exposed regions including the palm and
forearm are less restricted in overall community membership and highly
susceptible to temporal variability.

By contrast, other regions, including those with high sebaceous gland activity, are
much more exclusive. For example, the forehead harbors fewer bacterial species and
is largely dominated by Propionibacterium [14,15,17,20]. This observation is
congruent among multiple studies, and as such, represents a relatively consistent
trend. Whether this effect is inherent to the lipid-rich environment of the forehead,
or whether Propionibacterium can successfully restrict membership alone is
currently unknown. Regardless, this region appears largely invariant compared to
more diverse sites of the skin, and thus represents a more stable overall community
structure.

While compelling, the stratification illustrated by certain dry and sebaceous sites is
by no means absolute, as multiple sites of the skin are characterized by intermediate
diversity with both dominant and transient taxa [14,15]. Therefore, further research
will be necessary to determine the role of intrinsic host factors and extrinsic
microbial traits as they pertain to skin bacterial communities.
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Recent studies have also begun to elucidate the topographical diversity of fungal
communities on human skin [21]. Specifically, it was shown that Malassezia
predominated at core body and arm sites, but that discrete signatures could be
observed at the species level. For example, the face was dominated by Malassezia
restricta while the back, occiput (back of neck), and inguinal crease (groin) were all
characterized by higher levels of Malassezia globosa.

In contrast to these areas, regions of the foot such as the plantar heel, toenail, and
toe-web space were all defined by significantly greater amounts of fungal diversity.
While Malassezia was still detected in all samples, subjects were also colonized by
relatively high proportions of Aspergillus and Epicoccum. Interestingly, regional
localization was found to be the strongest determinant of fungal community
membership as feet, arms, the head, and torso all formed distinct communities
regardless of physiological environment. This suggests that while bacterial
populations are subject to factors such as sebum content and hydration, fungal
communities are more flexible in resource utilization, a less surprising realization
given their pronounced evolutionary differences.

2.4.2 Gender
The contribution of gender to skin microbial diversity likely arises as a downstream
effect of male and female steroid production [13]. For example, it is thought that
androgen expression and identity are both critical to sex-defined differences in skin
thickness [22,23]. Males also exhibit increased levels of sebaceous and sweat gland
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activity compared to females, a trait that strongly contributes to differences in skin
surface biochemistries [24,25]. Even the presence or absence of body hair could
presumably result in alternative microenvironments with the potential to support
the growth of niche-specific microorganisms. Interestingly, mixed results have been
observed in regard to gender and pH. While some studies have detected a more
acidic pH in female skin, others have demonstrated no differences [26-29]. This
suggests that variation in male and female physiologies have the potential to
influence microbial communities, but that certain factors likely contribute to skin
habitats more strongly than others.

With this in mind, a recent study that sampled the palmar regions of male and
female undergraduate students observed significantly different bacterial
communities on the skin surface in regard to gender [18]. While no taxa were
specific to either sex, there were marked differences in the relative abundances of
numerous bacterial groups. For example, Propionibacterium and Corynebacterium
were 37% and 80% more abundant in men, respectively, along with a trend towards
higher levels of Staphylococcus. By contrast, Enterobacteriales, Moraxellaceae,
Lactobacillaceae, and Pseudomonadaceae were all over 150% more abundant in
females. Women were also found to harbor significantly greater levels of alpha
diversity, a metric that defines “within” sample diversity and is often measured by
numbers of OTUs, their evenness, and their degree of phylogenetic difference.
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In contrast to these results, a study of healthy Chinese undergraduates showed no
significant differences between the palmar bacterial communities of men and
women [19]. However, higher relative abundances of distinct taxa such as
Propionibacterium, Corynebacterium, and Staphylococcus were once again observed
in male subjects while Lactobacillus was over-represented in females. Interestingly,
Enhydrobacter and Deinococcus also made up a large portion of female hand
communities, while Fierer, et al, found no such contribution in either sex. This
suggests that geographical or cultural aspects may also play a large role in
diversifying skin microbial communities, a concept that has been supported by a
number of additional reports as well [30,31].

In a study comparing the skin microbiota at varying developmental stages, males
and females between the ages of 2 and 40 were swabbed at the antecubital and
popliteal fossae, the volar forearm, and the nares [32]. In all, no significant
differences were observed between the bacterial communities of males and females
regardless of age group. Moreover, a study comparing the levels of
Propionibacterium and coagulase negative Staphylococcus in middle-aged men and
women found no significant differences at the forehead, cheek, upper chest, or back
[33]. However, it was found that males harbored greater total amounts of the fungi
Malassezia.

Studies have also examined the human axilla, upper buttock, forehead, and forearm
as potential sites of gender variability. Interestingly, the bacterial communities of

22

the axillary vault were found to stratify into two main groups, those colonized
predominantly by Staphylococcus and those with high relative abundances of
Corynebacterium [34]. While not absolute, female subjects were generally found
within the Staphylococcus cluster whereas males were more often associated with
the Corynebacterium cluster. Analysis of the upper buttock also exhibited a strong
effect of gender with males illustrating relatively high proportions of
Corynebacterium, Dermacoccus, Streptococcus, and Finegoldia while females
displayed elevated levels of Lactobacillus, Propionibacterium, Staphylococcus, and
Enhydrobacter [35]. Despite these distinctions, there were no significant differences
between genders when taking the entire microbial community into account,
suggesting that individualized signatures were still the best indicators of variability.

On the forehead, males and females were found to harbor differences in overall
bacterial diversity [17]. However, when accounting for the use of make-up,
significant variability between these groups was no longer detected. In contrast,
microbial diversity of the forearm was significantly different between men and
women at both the genus and species level.

In all, it appears that gender may contribute to microbial community structure, but
that the importance of this factor likely varies in a site-dependent manner. As male
and female physiology differs throughout the body, it is not surprising that the
contribution of gender to microbial communities is also inconstant. More detailed
studies will be necessary to determine the importance of potential driving factors,
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as no studies to date have measured microbial populations and biochemical
signatures in concert.

2.4.3 Age
The human skin begins to develop in utero during the first trimester of gestation,
and by 34 weeks, a well-defined stratum corneum has formed [36]. In the weeks
leading up to delivery, the epidermis further matures, and begins to resemble a
competent adult-like barrier by week 40 [36]. Upon birth, the skin undergoes a
number of rapid changes as it acclimates to a dry, gaseous climate very much at
odds with its former aqueous environment. During this time, the skin is
characterized by quantal bursts of improved barrier function that persist for
multiple weeks postnatal delivery [38]. Development then continues during the first
year, after which point infant skin begins to resemble that of mature adults [39].

During maturation, infant skin is defined by a thin layer of corneocytes that are, on
average, much smaller than adult corneocytes [40]. In addition, infant skin contains
lower lipid content resulting in an epidermal barrier with higher water levels and
increased permeability [39,41]. Neonates are also born with a relatively alkaline
skin pH that remains less acidic than adult skin for the first two years of life [42].

All of these developmental features likely contribute to the differences seen
between adult and infant bacterial communities. For example, Staphylococcus
species, which are known to predominate at moist body sites on the adult
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epidermis, have been found at significantly higher levels on neonatal skin. In fact, a
recent study of the infant microbiota observed that Staphylococcus and
Streptococcus species could account for up to 40% of skin bacterial populations
during the first six months of life, before giving way to a more diverse community
[43]. Interestingly, site-specificity also began to appear within the first few months
of life. Staphylococcus, Streptococcus, Corynebacterium, and Propionibacterium were
all found to predominate at the arm and forehead of infant skin while the buttock
was colonized by both gut- and skin-associated taxa such as Clostridium,
Staphylococcus, Streptococcus, and Ruminococcus. This suggests that as the skin
matures, it becomes more adept at influencing resident bacterial communities at
certain body sites.

Additional experiments have also examined the route of delivery as a direct
contributor to the human skin microbiota [44]. These analyses have shown that
vaginally born neonates harbor skin bacterial communities very similar to those
found in the vagina. This includes an abundance of both Lactobacillus and Prevotella.
In contrast, babies born by Cesarean section were colonized by common skin
residents such as Acinetobacter, Bacillales, Micrococcineae, and Staphylococcus.
Interestingly, this study also found that babies born through conventional methods
displayed skin bacterial communities most similar to their mother’s microbiota,
while babies born by Cesarean section were no more similar to their own mother
than any other subject. As such, while an initial vertical transmission of the bacterial
microbiota existed in vaginally delivered neonates, no such transmission occurred
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in babies delivered by Cesarean section. Rather it appears that incidental exposures,
likely provided by hospital staff and environmental surfaces, were the greatest
contributors to microbial communities in these subjects.

While the initial inhabitants of infant skin can vary greatly depending upon age and
delivery mode, their microbiomes appear to stabilize over time, reaching an adultlike community at sexual maturity. A study employing Tanner staging to distinguish
between children and adults found that the microbiota of subjects within Tanner
stages 1, 2, and 3 segregated significantly from that of individuals at stages 4 and 5
[32]. Similarly to above, it was also shown that higher levels of Proteobacteria and
Firmicutes such as Streptococcaceae distinguished the microbiota of younger
cohorts, while adolescents/post-adolescents were dominated by Propionibacterium
and Corynebacterium. This particular result corresponds well with the
developmental milestones reached at higher Tanner stages including elevated
hormone levels and increased sebaceous gland activity, as both factors promote the
growth of more lipophilic microorganisms [45].

Interestingly, it has also been shown that the common fungal commensal Malassezia
colonizes neonate skin during the birthing process [46]. At day 0 following delivery,
Malassezia DNA was successfully detected in 24 of 27 subjects, and by day 30
approximately 104 residents were estimated by qPCR. While the specific
distribution of Malassezia residents differed greatly in newborns compared to their
mothers, these rates stabilized to a level very near that of adulthood by day 30.
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Overall, these results suggest that the skin and its microbial inhabitants develop
together over time. While the physiological and biochemical attributes of the skin
contribute a great deal to microbial diversity, this niche also represents a blank slate
with the potential to accommodate a vast array of microbial organisms. For this
reason, further research will be necessary to fully elucidate the dynamic nature of
age-related succession.

It may also be necessary to revise the long-held belief that most fetuses develop in a
sterile environment. Recent evidence suggests that bacteria can be reproducibly
isolated from newborn meconium and umbilical cords of healthy, full-term neonates
[47,48]. Enterococcus faecium has also been isolated from newborn meconium and
amniotic fluid following oral inoculation of pregnant mice, and fluorescent in situ
hybridization can be used to visualize 16S rRNA-containing species deep within
human fetal membranes [47-49]. A recent study of the placental microbiome also
reported a diverse community of bacterial species characterized by increased levels
of Proteobacteria [50]. In addition, both Gram-positive and Gram-negative
intracellular bacteria have been detected in over a quarter of placental basal plate
samples [51]. These findings are in stark contrast to the notion that newborns are
not exposed to microorganisms until birth, and these microbes could contribute to
the initial inoculum present on newborn epidermis.
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2.4.4 Immune system
The host immune system and the skin microbiota are in constant communication as
each works to establish a steady equilibrium. This is not surprising given the
intimate contact made between the two. In fact, it is thought that as many as 107
bacteria/cm2 colonize the epidermis at any given time [52]. Although the vast
majority of these microorganisms inhabit the stratum corneum, recent evidence has
shown that bacterial species may also reside within deeper layers of the epidermis
and dermis [35,53]. For this reason, it is essential for hosts to control the cutaneous
immune response, and tailor it to a given threat, as persistent activation against
resident skin bacteria could lead to chronic inflammatory disorders.

To perform this function, the skin is equipped with a number of professional innate
and adaptive immune cells including multiple dendritic and T cell subsets (Figure
3). Keratinocytes also provide support through the expression of Toll- and Nod-like
receptors and the secretion of antimicrobial peptides, proinflammatory cytokines,
and chemokines [54]. Even melanocytes can assist in the overall immune response
by recognizing and responding to specific foreign antigens [55].

While all of these cells play a crucial role in epidermal barrier function, Langerhans
cells (LCs) are thought to act as the key initiators of cutaneous immunity by
sampling the upper strata for microbial antigens and presenting these peptides to
adaptive immune cells [56,57]. However, the exact role of these specific dendritic
cells has recently come into question, as many of the tasks previously attributed to

28

LCs, such as cross-presentation, may actually be performed in vivo by a separate
subset of myeloid cells known as dermal dendritic cells [58,59]. Regardless of
subtype, it appears that dendritic cells are crucial to mediating the initial response
to barrier disruption. Upon antigen uptake, these cells travel to cutaneous draining
lymph nodes where they present foreign peptides to naïve T cells. These T cells then
become activated and imprinted with skin-specific homing markers such as
cutaneous leukocyte antigen (CLA), CCR4, CCR8, and CCR10 [60-63]. The ligands for
these receptors are expressed at low levels during steady state, but they can be
upregulated during inflammation, allowing for the recruitment of effector T cells to
the skin epithelium. Upon antigen clearance, these mature T cells differentiate into
resident or effector memory T cell subsets. Resident memory CD8+ T cells are then
thought to remain within the epidermis while effector memory CD4+ T cells traffic to
more distal sites of the skin [64,65].

While this pathway has been established in response to infection, less information
exists in regard to the skin’s response to commensal microorganisms. Specifically, it
is currently unclear how the immune system can differentiate between pathogenic
and non-pathogenic species, especially when considering the close proximity of
keratinocytes, melanocytes, and LCs to conserved microbial antigens. A recent paper
sheds some light on this debate by suggesting that LCs may perform separate roles
depending on the state of epidermal tissue [66]. This group found that upon insult,
resident LCs were crucial for the activation of resident memory T cells. However, at
steady state, these cells promoted a homeostatic balance through the activation and
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preservation of regulatory T cells. While it is proposed that these regulatory T cells
are important for the maintenance of self-tolerance, this process could also regulate
the host immune response to resident skin microorganisms and inhibit excess
inflammation.

With this in mind, various groups have explored the direct interactions of skin
inhabitants with keratinocytes and the immune system. For example, the common
skin commensal bacterium Staphylococcus epidermidis has been found to activate
TLR2 signaling and the production of antimicrobial peptides and proinflammatory
cytokines, augmenting the immune response to both group A Streptococcus and HPV
infection [67-69]. The TLR2 ligand lipotechoic acid has also been shown to reduce
TLR3-mediated inflammation in keratinocytes and promote the induction of
cathelicidin-producing mast cells [70,71]. Interestingly, this effect does not appear
to extend to macrophages, dendritic cells, or mouse endothelial cells, as exposure in
these cell types results in an inflammatory response that is equal to or greater than
that of epidermal keratinocytes. Therefore, a division of labor may exist within the
cutaneous epithelium in which only certain cells can promote inflammation, a
finding supported by the differential expression of Toll-like receptors at distinct
layers of the epidermis [72].

Our lab and others have also focused on the relationship between host immunity
and skin bacterial residents in order to identify key members of this host-microbe
interaction network. By treating mice with a C5aR antagonist, we have shown that
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disruptions to the complement pathway can lead to significant changes in skin
community structure including an increase in Actinobacteria and a decrease in
Firmicutes [73]. We also observed a significant decrease in bacterial diversity
(defined as the number of OTUs and their evenness), upon treatment, as well as a
reduction in the overall number of bacterial OTUs. In addition, the expression of
antimicrobial peptides, cytokines, chemokines, cell adhesion molecules, and pattern
recognition receptors were all reduced in antagonist-treated mice, along with
decreased levels of immune cell infiltration. This suggests that complement proteins
may act to induce and/or maintain stable levels of these effectors, and that
alterations to this balance can significantly shape skin microbial populations. The
expression of complement genes in the skin of germ-free and conventionally-raised
mice were also compared to determine the importance of bacterial stimulation to
complement gene expression. In the absence of bacterial colonization, we observed
significantly lower expression of over 30 genes related to complement activation
and binding, indicating that both the skin and its resident microorganisms are
capable of influencing the identity of their respective interaction partners.

The ability of the immune system to shape bacterial communities has also been
observed by comparing the skin microbiota of healthy and immunocompromised
mice [74]. Here, it was found that healthy mice were colonized by an abundance of
Proteobacteria including Acinetobacter, Escherichia/Shigella, and Acidovorax while
immunodeficient mice were dominated by Firmicutes, especially those of the
Staphylococcus genus. This difference was borne out in diversity metrics as well,
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with healthy mice displaying a significantly greater degree of variation when
compared to immunodeficient mice.

Importantly, a recent study of humans with primary immunodeficiencies (PIDs)
shows that this effect is not limited to murine models [75]. PID patients were
defined by increases in microbial permissiveness to atypical microorganisms such
as the opportunistic pathogen Serratia marcescens. Depending on the specific PID,
patients were also characterized by decreases in site specificity, interpersonal
variation, and longitudinal stability, suggesting a generalized dysbiosis caused by
alterations to the host immune response. Paradoxically, these changes did not result
in significant alterations to microbial diversity, however, indicating that site-specific
restraints in humans may still control overall community structure.

Work has also compared the adaptive immune systems of germ-free (GF) and
specific-pathogen free (SPF) mice to determine the importance of commensal
bacteria to cutaneous immunity [76]. This study found that skin bacterial residents
influence T cell number and function, as GF mice had higher levels of Foxp3+
regulatory T cells and lower amounts of the cytokines IFN-γ and IL-17A.
Importantly, this effect on IL-17A could be rescued by monocolonization with the
skin commensal bacterium Staphylococcus epidermidis. These results were also
extended to infection by the parasite Leishmania major. In this model, GF mice were
unable to mount a robust immune response to L. major while monoassociation with
S. epidermidis could restore protection in an IL-17A-dependent manner. IL-1α
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expression was essential for this response, as neutralization of this cytokine
impaired the restoration of IL-17A signaling. As such, it appears that IL-1 signaling
pathways are enhanced by the skin microbiota, and that this response can promote
overall skin immune fitness.

A more recent report supports this finding by confirming the ability of T cells to
shape skin bacterial communities [77]. Adoptive transfer of T cells from WT mice
into Rag1-/- mice resulted in the rapid proliferation of both CD4+ and CD8+ T cells
within skin draining lymph nodes, consistent with a memory immune response to
skin bacterial antigens. The number of live bacteria and 16S rRNA bacterial
sequences were also higher in Rag1-/- compared to WT mice, and the transfer of T
cells from WT to immunodeficient mice resulted in a steady decline of these
markers. This response was abrogated in the absence of IL-17A and IFN-γ, while B
cell deficient mice mirrored WT phenotypes, suggesting that certain T cell profiles
are essential for the recognition and control of skin bacterial residents.

In all, these results indicate that the immune system and skin microbiota are in
constant communication, and that each is necessary to promote homeostasis at the
skin surface. However, these interactions appear to vary greatly depending on the
specific immune cell subset and signaling pathway, and perhaps even the conditions
in which mice are housed. Indeed one group recently reported no differences
between the skin microbiota of healthy and immunocompromised mice, although
variation is readily detectable when comparing the mice within different
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experimental groups [78]. As such, further research will be necessary to describe
the intimate relationship between hosts and bacterial inhabitants, and to determine
the key players of this particular host-microbe interaction network.

2.5 Host-microbiome interactions in cutaneous disease
Many cutaneous disorders are caused by, or associated with, overt microbial
infection. Here we focus on three of these disorders: acne vulgaris, psoriasis and
atopic dermatitis. While complex in etiology, these conditions are thought to involve
both microbial and host components. In addition, studies of these diseases have
included deep sequencing approaches as a means to elucidate the contribution of
skin microbial communities to disease pathology. As such, these disorders represent
a model system to study the interactions of host factors and bacterial residents as
they pertain to disruptions in skin homeostasis.

2.5.1 Acne
Acne vulgaris is one of the most prevalent skin diseases in the world, representing a
financial burden of over 3 billion dollars per year in the United States alone [79].
Despite this figure and studies showing that acne can affect approximately 80% of
adolescents and young adults [80], relatively little is known in regard to the events
underlying this disorder. In particular, it remains unclear whether: (i) comedone
formation is the cause or effect of inflammation in pilosebaceous follicles, (ii) which
immune cells and cytokines drive the overall inflammatory response, and (iii) the
specific role of skin microbial residents such as Propionibacterium acnes.
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Over the past decade, a number of groups have begun to address these questions,
outlining a multifactorial process driven, in large part, by increases in androgen
production during puberty. This increase in hormone signaling activates sebaceous
gland activity and induces epithelial hyperproliferation and keratinization [81].
These changes can then promote the colonization and growth of Propionibacterium
acnes, and contribute to the chronic inflammation seen in affected pilosebaceous
follicles.

Multiple in vitro studies have demonstrated the ability of P. acnes to increase the
expression of key inflammatory cytokines such as IL-1α, IL-1β, IL-6, IL-8, IL-12, and
TNF-α by human sebocytes, keratinocytes, and monocytes [82-84]. The presence of
infiltrating CD4+ T cells has also been observed by a number of groups, suggesting
that the recruitment of these cells could promote inflammation within acne lesions
[85-87].

Recently, a number of independent reports confirmed the ability of P. acnes to
upregulate the production of IL-1β through the activation of the NLRP3
inflammasome [88-90]. Higher expression levels of NLRP3 and caspase-1 were
observed in the areas surrounding acne lesions and both markers co-localized with
infiltrating tissue macrophages [88,90]. Mice challenged with P. acnes also showed
increased expression of caspase-1 and IL-1β, while NLRP3 knockout mice displayed
a significant decrease in these inflammatory markers [89,90]. In sebocytes, this
activity was dependent upon reactive oxygen species and P. acnes protease activity,
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while monocytes required bacterial uptake, potassium efflux, and reactive oxygen
species [88-90]. This information, coupled with studies showing increased
expression of TLR-2 on acne-localized macrophages [83], suggests a mechanism by
which monocytes are recruited to early acne lesions, and then activated by P. acnes
to induce a more robust inflammatory response.

Recent studies have also demonstrated the ability of P. acnes to stimulate Th17
differentiation and activity. These reports have shown that IL-17-expressing cells
often localize to affected pilosebaceous follicles and are elicited by the production of
IL-1β, IL-6, and TGF-β [91]. In addition, P. acnes-reactive Th17 cells were isolated
from the blood of acne patients at higher frequencies than those of healthy subjects
[92]. Two commonly employed dermatologic acne treatments, all-trans retinoic acid
and 1,25-dihydroxyvitamin D3, were also found to downregulate P. acnes-induced
IL-17 mRNA and protein expression [91]. Together these results suggest that CD4+
Th17 cells may be key mediators of the chronic inflammation found within
moderate-to-severe acne lesions, and that modulation of these cells could resolve
certain aspects of P. acnes-induced pathology.

While convincing, these results do not address the fact that P. acnes is a common
skin inhabitant regardless of acne phenotype. Rather, reconciliation with this
observation has come in the form of more detailed experiments describing the
specific localization and genetic-signatures of individual P. acnes clones. These
studies have shown that pilosebaceous follicles are more frequently colonized by P.
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acnes in affected, compared to unaffected, individuals [93,94]. This bacterium is also
found more commonly as macrocolonies within acne lesions in contrast to the
sparse distributions that typically attach to the outer surface of the epidermis in
healthy individuals [93,94]. Interestingly, within these follicles, multiple strains of P.
acnes have been observed, but only certain strains, such as subtype IA, are
associated with acne vulgaris [94-97]. A recent study utilizing 16S rRNA gene
sequencing of P. acnes populations confirmed this finding by isolating certain
subtypes of P. acnes from acne patients more frequently than others [98].
Interestingly, this group also reported a specific phylotype of P. acnes that
associated more commonly with healthy subjects compared to acne patients,
underscoring the importance of strain-specific profiles in P. acnes pathogenesis.

Overall, it appears that androgen-induced increases in sebum production during
puberty may promote P. acnes colonization, but that this effect is not necessarily
emblematic of disease. Rather, the growth of specific P. acnes strains may be
required for acne lesions to develop into fully mature papules and pustules. Indeed,
studies have reported a differential immune response in sebocytes and
keratinocytes when exposed to alternative strains of P. acnes, a characteristic that
could explain the ubiquity of P. acnes in both affected and unaffected individuals
[82,99].
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2.5.2 Psoriasis
Psoriasis is a common inflammatory disease affecting approximately 2-3% of the
world’s population [100]. While multiple phenotypes exist, this condition is often
characterized by well-demarcated erythematous plaques, resulting from chronic
inflammation and the hyperproliferation of keratinocytes [101]. At onset, an initial
inflammatory event is thought to precede plaque formation and induce the
production of numerous proinflammatory cytokines. Further inflammation is then
promoted by CD4+ Th1, Th17, and Th22 cells leading to distinct changes in skin
architecture [102]. These include the thickening of epidermal cell layers, elongation
of epidermal rete ridges, hypogranulosis, and parakeratosis [103].

Genome-wide association studies have largely supported these phenotypic
observations with most identified defects belonging to the IL-23/Th17 axis, NF-κB
pathway, and epidermal differentiation complex [104-106]. However, the major
genetic determinant of psoriasis is found within the HLA-Cw0602* allele of the MHC
class I molecule, HLA-C [107]. Mutations within this locus are thought to account for
approximately 60% of all psoriasis cases suggesting that CD8+ T cells may also play
a major role in disease pathogenesis [108].

Although a number of pharmaceutical drugs are currently available to mediate the
inflammatory nature of psoriasis, little is known in regard to the source of this
inflammation. Physical trauma (Koebner’s phenomenon) and infection have both
been associated with the induction of psoriatic flares [109,110]. This is supported
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by the observation that surgical procedures and streptococcal throat infections
often precede lesion formation [103,111-113]. However, no study to date has
identified an antigen capable of eliciting a complete psoriatic phenotype in healthy
skin, despite links between superantigens and certain streptococcal surface proteins
[114-116]. It is interesting to note that while infection of the throat with
streptococcal species is the best-studied site of proclivity, Streptococcus is also a
common resident of the skin [14-16]. As such, physical trauma and infection need
not be mutually exclusive events if injury results in the presentation of
streptococcal-associated (or alternative bacterial) antigens.

In this vein, a number of groups have attempted to characterize the microbiota of
psoriasis plaques in search of inflammatory antigens and disease-associated
microbial signatures. The first of these found an overabundance of Firmicutes in
psoriasis skin compared to uninvolved skin, while Actinobacteria were significantly
underrepresented at affected skin sites [117]. Psoriasis plaque communities were
also more diverse than unaffected skin with elevated
Streptococcus/Propionibacterium ratios. Unfortunately, this particular analysis
employed an unmatched study design, raising the possibility that observed
differences could also be due to variation between microbial communities at distinct
topographical sites.

To address this concern, more recent studies have employed a matched control
design that compares identical unaffected/affected skin sites. The first utilized skin
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biopsies to study microbial populations on the trunk, arms, and legs of affected
individuals [118]. This group found no differences in alpha or beta diversity
between psoriatic and normal skin. Moreover, when taking body site into account,
no differences were observed between Firmicutes or Actinobacteria species at the
trunk or limbs. Proteobacteria were found to be significantly greater in trunk
psoriasis samples compared to the control group, however this result was not
significant when comparing the legs and arms of psoriasis subjects to controls.
Similar to above, the ratio of Streptococcus/Propionibacterium was elevated in the
psoriasis group with respect to controls, but this result was largely due to the
absence of Propionibacterium in a number of psoriasis samples, rather than
significant fluctuations in streptococcal species.

More recently, Alekseyenko et al. compared swabs of psoriasis lesions to unaffected
skin sites and demographically-matched controls [119]. While trending towards
decreased alpha diversity, no significant differences in this metric were detected
between lesions, unaffected sites, or control samples at the OTU level. There were
also no differences in the relative abundances of Firmicutes or Actinobacteria.
Notably, Proteobacteria were found at significantly higher levels in unaffected skin,
in contrast to the abovementioned study. Plaque specimens also displayed the
greatest intragroup diversity while unaffected skin from psoriasis patients was
more similar to control skin. This suggests that psoriasis plaques may be more
permissive to alternative phylotypes, while unaffected skin may retain its ability to
influence microbial populations.
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In all, these studies indicate that skin bacterial communities from affected subjects
may be shifted in a modest, but significant manner. Given the intrapersonal
variability of the microbiota at sites with disease predilection, it is also possible that
stochastic differences between subjects are masking additional, more subtle trends.
For this reason, longitudinal comparisons of subjects may prove more valuable as a
means to survey the skin over time and monitor each individual with respect to
his/her unique microbial community. This is especially important when considering
disorders such as psoriasis, in which alterations to the microbiota appear less
pronounced.

2.5.3 Atopic Dermatitis
Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects 10-20% of
the childhood population [120]. This condition initially appears as an eczematous
rash with pruritis and erythema, but during later stages of disease these lesions can
mature into lichenified plaques [121]. AD also predisposes individuals to increased
prevalence of asthma, allergic rhinitis, and food allergies - a condition known as the
“atopic march” [122]. Unlike psoriasis, AD is a CD4+ Th2-mediated disorder with IL4, IL-5, and IL-13 driving initial inflammatory events [123-126]. Upon sensitization,
epidermal cells secrete pro-inflammatory cytokines such as thymic stromal
lymphopoietin (TSLP), IL-25, and IL-33 [127-129]. This response then promotes a
Th2-specific immune response which can lead to elevated infiltration by mast cells,
eosinophils, and allergen-specific IgE [130-132].
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Similar to the aforementioned conditions, the underlying cause of AD pathology also
remains unclear. Although both immune dysfunction and epidermal abnormalities
have been implicated by GWAS analyses, loci associated with cutaneous barrier
function have been associated most strongly with the disease, specifically mutations
in the filament-aggregating protein, filaggrin [133]. Filaggrin is a major structural
protein of the epidermis that aligns keratin filaments and contributes to the
contractile strength of the stratum corneum [134]. Over time, filaggrin is also
broken down into natural moisturizing factors and amino acid derivatives to assist
in the hydration and acidification of the stratum corneum [135]. As such, this
protein represents an essential member of the epidermal differentiation complex.

Because of the strong association between FLG mutations and AD, it is generally
thought that disruptions to the epidermal barrier predispose the skin to allergen
sensitization and immune dysfunction. However, this alteration in structure cannot
fully explain the development of AD, as approximately 40% of patients with FLG
mutations often fail to develop the characteristic lesions seen in affected individuals
[136]. FLG expression can also be downregulated in patients with wildtype FLG
alleles, suggesting that filaggrin levels and activity could be affected by peripheral
means [137]. Indeed, exposure to the cytokines IL-4 and IL-13 can reduce
expression of FLG, suggesting an alternative model in a subset of individuals
whereby immune dysregulation could portend epidermal barrier abnormalities
[138].
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Interestingly, a number of studies also suggest that AD can promote colonization of
the skin by Staphylococcus aureus. While S. aureus is a rather infrequent inhabitant
of extranasal body sites in healthy individuals, it has been shown to colonize >80%
of patients with AD [139-141]. In support of this, a recent study utilizing 16S rRNA
gene sequencing found that Staphylococcus species, specifically S. aureus and S.
epidermidis, dominated atopic lesions, while the common skin residents
Corynebacterium, Streptococcus, and Propionibacterium were all significantly
reduced [142]. The relative abundances of S. aureus were also correlated with AD
disease severity, similarly to previous reports, indicating an increased propensity
for S. aureus to colonize AD lesions [140,141,143].

This increase in colonization has been hypothesized to occur for a number of
reasons including a rise in the availability of S. aureus binding receptors, decreases
in the expression of antimicrobial peptides (AMPs), and elevated levels of IL-4
expression. In this regard, the lack of an intact stratum corneum in AD skin could
expose extracellular matrix proteins to the surface and promote S. aureus
colonization. Indeed, S. aureus adherence to the skin is reduced following
preincubation with fibrinogen or fibronectin, and S. aureus strains lacking
fibrinogen- and fibronectin-binding proteins illustrate significantly impaired
binding to AD skin [144,145]. The cytokine IL-4 has also been shown to upregulate
the production of fibronectin by dermal fibroblasts while binding of S. aureus to the
skin is significantly impaired in IL-4 knockout mice [144,146].
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Unfortunately, the importance of antimicrobial peptides to S. aureus colonization
remains unclear. It was initially thought that reduced expression of AMPs in atopic
skin could eliminate a key barrier to S. aureus colonization. In support of this,
numerous studies have reported decreased expression of AMPs in AD-affected skin
compared to that of psoriatic lesions [147-149]. However, more recent data
comparing the levels of antimicrobial peptides in AD skin to that of unaffected
controls has shown increased expression of multiple AMPs including RNase 7,
psoriasin, hBD-2, hBD-3, and LL-37 [150,151]. Therefore, the previously ascribed
reduction of AMPs in AD skin may be due more to the upregulation of these genes in
psoriatic skin, rather than their decreased production in atopic individuals.

In all, it appears that both barrier disruptions and improper immune activation
contribute to lesions in AD patients. While the underlying cause of inflammation
remains unclear, it is likely that this determinant involves a combination of genetic
and environmental factors. Notwithstanding, AD pathology consistently leads to
shifts in skin microbial communities including an increase in staphylococcal species
such as S. aureus. While this observation is a satisfying explanation for the increased
prevalence of S. aureus infections in AD patients, it is perhaps more striking that this
rate is not higher [152]. S. aureus levels have been found to reach 107 CFU/cm2 in
uninfected individuals [139,140], indicating that affected subjects may retain the
ability to limit S. aureus pathogenesis despite a number of immune abnormalities. As
such, a compartmentalized response in AD patients may exist, similarly to that seen
in the gut, whereby atopic lesions can unintentionally promote the growth of S.
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aureus at the skin surface while simultaneously opposing infection of the underlying
tissues.

2.6 Concluding remarks
Advances in sequencing technology have enhanced our ability to characterize
cutaneous microbial communities in a more precise and accurate manner, and as a
result, our knowledge regarding host-microbe interactions in skin health and
disease is steadily increasing. As these insights are deepened and developed, a
major challenge will be to translate this knowledge into strategies that improve skin
health and cutaneous diagnostic techniques. Future analyses employing shotgun
metagenomics and metabolomics are essential to this goal, as we work towards a
better comprehension of skin microbial population dynamics. Indeed a recent study
of the skin microbiome utilizing metagenomic approaches has contributed greatly to
our understanding of skin bacterial communities (153). Studies such as these are
crucial to our perception of cutaneous microorganisms and can inform future
experimental approaches. Only following these initial characterizations can we hope
to truly appreciate the dysbiotic states associated with disease, and only then can
we strive to successfully elucidate the importance of microbial inhabitants to
hominal equilibria.
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2.8 Figures

Figure 1 Skin structure and morphology. The skin can be divided into two main
layers, the epidermis (E) and dermis (D), and underlying regions of subcutaneous
fat (SF). Hair follicles (HF) extend from the skin surface into the dermis and are
often associated with sebaceous glands (SG). The epidermis contains distinct layers
of keratinocytes at varying stages of development. Basal stem cells are found at the
stratum basale while daughter cells mature to populate the stratum spinosum,
stratum granulosum, and upon terminal differentiation, the stratum corneum.
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Figure 2 Regional variation of skin microbial communities. The cutaneous
microbiota varies according to body site and is strongly influenced by differences in
cutaneous physiological environments. Each pie chart represents the mean bacterial
community of a given biogeographic region. Sebaceous (red), moist (blue), and dry
(green) regions are highlighted. Data from Grice et al. [13].
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Figure 3 Major skin immune cell subsets. Human skin is characterized by an array
of innate and adaptive immune cells. In the epidermis, this includes Langerhans
dendritic cells and CD8+ T cells. The dermis is home to a more varied population of
innate dermal dendritic cells, NK cells, and mast cells, as well as adaptive CD4+ Th1,
Th2, Th17, and Th22 cells.
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CHAPTER 3 - Topical antimicrobial treatments can elicit shifts to
resident skin bacterial communities and reduce colonization by
Staphylococcus aureus competitors

The contents of this chapter are under review for publication with the authors:
SanMiguel AJ, Meisel JS, Horwinski J, Zheng Q, Grice EA.

3.1 Abstract
The skin microbiome is a complex ecosystem with important implications for
cutaneous health and disease. Topical antibiotics and antiseptics are often employed
to preserve the balance of this population, and inhibit colonization by more
pathogenic bacteria. Despite their widespread use, however, the impact of these
interventions on broader microbial communities remains poorly understood. Here
we report the longitudinal effects of topical antibiotics and antiseptics on skin
bacterial communities and their role in Staphylococcus aureus colonization
resistance. In response to antibiotics, cutaneous populations exhibited an immediate
shift in bacterial residents, an effect that persisted for multiple days post-treatment.
By contrast, antiseptics elicited only minor changes to skin bacterial populations,
with few changes to the underlying microbiota. While variable in scope, both
antibiotics and antiseptics were found to decrease colonization by commensal
Staphylococcus spp. by sequencing- and culture-based methods, an effect which was
highly dependent on baseline levels of Staphylococcus. Because Staphylococcus
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residents have been shown to compete with the skin pathogen S. aureus, we also
tested whether treatment could influence S. aureus levels at the skin surface. We
found that treated mice were more susceptible to exogenous association with S.
aureus, and that precolonization with the same Staphylococcus residents that were
previously disrupted by treatment could reduce S. aureus levels by over 100-fold. In
all, this study indicates that antimicrobial drugs can alter skin bacterial residents,
and that these alterations can have critical implications for cutaneous host defense.

3.2 Introduction
Antimicrobial drugs are commonly employed to inhibit the growth of pathogenic
microorganisms. However, these interventions are rarely narrow in spectrum,
instead acting on a range of bacterial species in our commensal microbiota (1). A
number of studies have elucidated this effect in gut microbial populations,
describing a dramatic reorganization of resident communities (2). This includes
decreased bacterial diversity, and outgrowth by previously minor contributors (35). Importantly, these alterations can persist for months to years post-treatment (68), and also affect a number of host functions including metabolism, immunity, and
transcriptional regulation (9, 10).

Despite these findings, few studies have assessed the impact of antimicrobial drugs
at alternative body sites such as the skin. Rather the majority of research at this site
has been devoted to a subset of easily cultured microorganisms studied in isolation
(11). This includes minimum inhibitory concentration tests of pathogenic skin
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bacteria, as well as exogenous colonization studies in which non-resident, test
microorganisms are applied to the skin prior to treatment (12). While these results
are often applied more broadly, their main purpose is to inform the effect of
antimicrobial drugs on transient, infectious bacteria, rather than more stable
members of the community (13). As such, few studies have truly assessed the
impact of antimicrobial drugs on inhabitant cutaneous populations. This dearth of
research is especially notable given the frequency with which humans disrupt skin
bacterial communities in both clinical and non-clinical settings. Indeed the intent of
most antiseptics is to sterilize the skin by employing agents with non-specific
mechanisms of action (14), with little regard for their effect on the resident
microbiota.

While culture-independent surveys have recently illuminated the complexity of the
skin microbiota (15-17), its necessity for normal function and disease remains
unclear. One postulated function includes a role in colonization resistance, whereby
members of the commensal microbiota could protect the host from infection by
opportunistic and pathogenic skin microorganisms (18). This particular process has
been well-documented in the gut. Here numerous studies have highlighted the
ability of bacterial residents to impair colonization by pathogenic bacteria through
immune activation, nutrient exclusion, and the production of toxic metabolites (19).
Antibiotics have also been shown to shift the resident microbiota, and render hosts
more susceptible to certain pathogenic bacteria (20). This includes studies of the
sporulating bacterium Clostridium difficile, which can recur repeatedly in response
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to antibiotic treatment, but can also be controlled in most patients following the
administration of fecal material from healthy, unaffected donors (21-23).
Importantly, this particular effect is not isolated to C. difficile, as a number of
bacterial pathogens including vancomycin-resistant Enterococcus and Salmonella
enterica have been shown to exploit newly available niches in response to treatment
as well (24-26).

Similar to the gut, recent studies have begun to assess the potential for skin
microorganisms to play a role in colonization resistance. This includes defense
against Staphylococcus aureus by unique strains of S. epidermidis (27), S. lugdunesis
(28), and most recently S. hominis (29). Here, it was found that certain individuals
are colonized by host-specific Staphylococcus strains with the ability to alter S.
aureus colonization patterns. While these studies also suggest that a removal of
resident bacteria with antimicrobial agents could promote S. aureus colonization, no
study to date has assessed this hypothesis in detail. Indeed, the long-term impact of
topical antimicrobial drugs on skin bacterial communities, and their ability to alter
colonization patterns by S. aureus competitors, remains largely unknown.

Here we report this missing link by assessing the effect of antibiotics and antiseptics
on the resident skin microbiota through a comparative time-series analysis. We
report a differential impact of treatment on skin bacterial inhabitants, with the
greatest disturbances elicited by a broad-spectrum triple antibiotic cocktail of
bacitracin, neomycin, and polymyxin B. By contrast, we report a relatively muted
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effect of antiseptics, with only modest alterations to overall bacterial community
structure. Despite these differences, we identified a conserved decrease in the levels
of Staphylococcus residents regardless of treatment, a result that was strongly
influenced by baseline levels of Staphylococcus.

Because commensal Staphylococcus spp. have been shown to impair colonization by
the skin pathogen Staphylococcus aureus, we further evaluated this antimicrobial
effect in the context of S. aureus colonization resistance. We show that treatment can
promote exogenous association with S. aureus, and that the same Staphylococcus
residents disrupted by treatment are also capable of S. aureus competition,
decreasing S. aureus levels by over 100-fold in precolonization experiments. In all,
our results demonstrate that antimicrobial drugs can elicit long-term shifts in skin
bacterial communities, and that treatment with these agents has key implications
for host susceptibility to pathogens such as S. aureus.

3.3 Results
3.3.1 Topical antibiotic treatment alters skin bacterial residents
To assess the impact of topical antibiotics on the skin microbiota, we began by
treating the dorsal skin of SKH-1 hairless mice twice daily for one week with the
narrow spectrum antibiotic mupirocin; a broad spectrum triple antibiotic ointment
(TAO: bacitracin, neomycin, polymyxin B); or their respective vehicles, polyethylene
glycol (PEG) and petrolatum (Fig. S1a). In all, antibiotics led to durable changes in
skin bacterial residents, with populations forming three distinct clusters (I – III) and
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four sub-clusters (IIIA-D) (Fig. 1a). Interestingly, Clusters I and IIIA were composed
largely of baseline and early time point samples high in Staphylococcus, while
treatment with antibiotics led to sustained decreases in Staphylococcus (Fig. S1b)
and alternative clustering patterns. Cluster II, by contrast, was composed almost
entirely of TAO-treated mice, a group that exhibited significant increases in
Enterobacteriaceae, Porphyromadaceae, and Ruminococcaceae, as well as
significant decreases in Lachnospiraceae and certain taxa classified more generally
within the Clostridiales family (Fig. 1b-d). This distinction led to a marked absence
of TAO-treated mice from Clusters IIIB-D, and, similar to Staphylococcus, was
sustained for multiple weeks post-treatment.

Unlike TAO-treated mice, those administered mupirocin displayed community shifts
largely in line with those treated with the vehicle PEG. Indeed while these mice
exhibited significant increases in Alistipes and decreases in Oscillibacter and
Staphylococcus (Fig. S1b, S1c), these minor changes were not enough to elicit
separate clustering patterns amongst the two treatment groups. These particular
changes also displayed similar kinetics to bacterial taxa in TAO-treated mice, i.e.
immediate increases and sustained post-treatment effects, underscoring the
difficulties faced by skin communities when attempting to re-acclimate upon
treatment cessation.

Analysis of bacterial burden revealed a contrasting effect of antibiotics on absolute
abundance, with only mupirocin leading to the characteristic decreases often
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associated with antibiotic treatment (Fig. S1d). TAO treatment, by contrast, resulted
in increased bacterial burden suggesting that the elevated levels of
Enterobacteriaceae and Porphyromonadaceae were due not just to increases in
relative proportions, but also overall numbers.

3.3.2 Topical antibiotics shift bacterial community structure
To better quantify these results at the community-level, we next evaluated the
diversity of bacterial populations over time. Similar to taxonomic analyses, we
observed a relative stability in untreated mice and those treated with PEG,
mupirocin, and petrolatum when testing alpha diversity metrics such as Shannon
diversity, which takes into account the richness and evenness of taxa (Fig. 2a). By
contrast, those treated with TAO exhibited an immediate and significant decrease in
diversity starting after a single day (d1) of treatment, an effect that was maintained
for greater than one week post-treatment. This was also recapitulated when
evaluating community similarity by the weighted UniFrac metric, which assesses
population differences based on abundance and phylogeny. When comparing each
mouse to their baseline (d0) samples, we observed significantly greater differences
within the TAO-treated group compared to vehicle-treated mice, a trend not shared
by those administered mupirocin (Fig. 2b). Additional visualization of these samples
by principle coordinates analysis further confirmed these results, as distinct
clustering patterns were observed when comparing TAO-treated mice to other
treatment groups (Fig. 2c).
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Previously, others have shown similarities in the functional composition of a
population despite differences in community membership and structure (30). To
evaluate whether antibiotic treatment could lead to changes in the functional
potential of skin inhabitants, we also utilized the PICRUSt software package (31) to
infer metagenomic content of our populations. Specifically, PICRUSt analysis focuses
on chromosomally-encoded, conserved differences amongst species as a method to
approximate functional disparities. We found that treatment with antibiotics and
vehicles led to a number of significant differences in genes associated with
metabolism, signaling, transport, and biosynthesis, among others (Fig. S2). As such,
the potential exists that by shifting the residents of the cutaneous microbiota,
treatment may shift the functional capabilities of these populations as well.

3.3.3 Antiseptic treatment elicits only modest changes to skin bacterial
community structure
Following our tests with antibiotic regimens, we next endeavored to evaluate the
impact of antiseptics, a more promiscuous class of antimicrobials, on the skin
microbiome. We reasoned that these topical interventions should provide an even
greater impetus for community disruption due to their indiscriminate mechanisms
and proven efficacy in clinical settings (14). To evaluate this hypothesis, we treated
mice with the common clinical antiseptics alcohol (80% ethanol) or povidone-iodine
(10%), and compared this to mice treated with water or untreated controls (Fig.
S3a). Surprisingly, we observed no clustering of mice in response to treatment when
taking into account major taxonomic groups (Fig 3a). Furthermore, when comparing
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the relative abundances of individual taxa, we detected no significant differences
among treated mice and untreated controls (Table S1). To evaluate whether subtle
differences could contribute to a disruption at the population level, we also tested
the diversity of communities in response to treatment. Similar to our taxonomic
analyses, we found that antiseptic treatment resulted in no significant differences to
Shannon Diversity (Fig. 3b), nor could we detect significant clustering by treatment
using beta diversity metrics such as weighted UniFrac (Fig. 3c). To assess whether
we had missed decreases in absolute abundance by focusing our analyses on the
relative proportions of taxa, we also tested the impact of treatment on the bacterial
load of communities. Once again, we observed no significant differences between
treated and untreated mice (Fig. 3d), underscoring the stability of cutaneous
bacterial communities in response to antiseptic treatment.

As this result was particularly surprising, we further compared bacterial phylotypes
at baseline to their d1 counterparts. This allowed us to evaluate whether treatment
could shift populations in a conserved manner, thus explaining the modest effects
seen between regimens at d1 post-treatment. However, when comparing the
abundances of major taxonomic groups, we once again observed relatively few
changes from d0 to d1 in response to treatment. Only Staphylococcus differed
significantly, and only in response to alcohol treatment (Table S2). Interestingly, this
effect was strongly dependent upon starting communities, as mice with higher
baseline levels of Staphylococcus were more strongly disrupted than those with
lower baseline levels, regardless of treatment (Fig S3b.). In all, this indicates that
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antiseptics elicit a more muted response in skin bacterial populations, but that their
effects may be dependent upon starting communities.

3.3.4 Culture-based studies recapitulate sequence analyses of skin microbiota
dynamics
Our finding that most antiseptics elicited only minor changes to the resident skin
microbiota was particularly surprising given the wealth of data describing their
benefit in clinical settings. To address this discrepancy, we next sought to validate
our findings using culturable skin inhabitants. Specifically, Staphylococcus was
chosen as a proxy because of its established response to topical antimicrobials in the
clinic and its importance to human health. These bacteria were also the only
inhabitants to vary in response to both antibiotics and antiseptics in our sequencing
experiments, and thus represented the best opportunity to verify our results in a
culture setting.

Because our antiseptic experiments exhibited an antibacterial effect dependent
upon baseline communities, we began by designing a system to control
Staphylococcus levels in murine populations. Specifically, we observed that mice
housed in cages changed once per week displayed significant elevation in
Staphylococcus levels (high Staphylococcus; HS) compared to those changed more
frequently (low Staphylococcus; LS) (Fig 4a). When controlled over time, this effect
could be maintained for multiple weeks and had the potential for reversibility, as
mice swapped from frequent to infrequent cage changes rapidly converted to the
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alternate phenotype. Cage change frequency and monitoring thus presented the
opportunity to maintain Staphylococcus at distinct levels prior to treatment.

To evaluate the impact of antimicrobial drugs on culturable Staphylococcus, we
began by housing mice in cages with frequent or infrequent changes, and then
treating with PEG, mupirocin, petrolatum, or TAO. Similar to sequencing
experiments, antibiotic treatment led to a significant decrease in Staphylococcus
starting at d1 post-treatment regardless of starting community, although this effect
was more pronounced in LS mice (Fig. 4b,c). Interestingly, while we also observed a
gradual decrease of Staphylococcus in response to PEG treatment, petrolatumtreated LS mice displayed increased Staphyloccocus colonization at early time
points, and elevated levels of Staphylococcus compared to untreated controls in HS
mice. Because our sequencing results revealed similar decreases in Staphylococcus
in response to treatment with antibiotics, but not petrolatum, this represents a
reproducible mechanism in multiple testing protocols.

To assess this effect in the context of antiseptics, a separate cohort of HS and LS
mice were next treated with water, alcohol, or povidone-iodine, and compared to
untreated controls. Unlike those treated with antibiotics, no significant differences
in Staphylococcus were observed in LS mice following treatment with water, alcohol,
or povidone-iodine compared to baseline colonization (Fig. 4d). Moreover, while HS
mice were significantly decreased in Staphylococcus following treatment, untreated
mice with a single cage change exhibited an almost identical reduction in
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colonization, confirming that a change in environment can also have significant
impacts on bacterial communities (Fig. 4e). In all, these experiments indicate that
antibiotics and antiseptics have distinct effects on skin bacterial residents, and that
the magnitude of this response can vary depending upon starting communities.

3.3.5 Antimicrobial drugs reduce colonization by Staphylococcus aureus
competitors
After confirming our sequencing results with culture experiments, we next
endeavored to explore the ramifications of cutaneous bacterial community
disruption. As previous studies have suggested a role for the skin microbiota, and
specifically resident Staphylococcus spp., in S. aureus colonization resistance (2729), we chose this particular commensal-pathogen pair for further analysis. We
were particularly attracted by the ability of antimicrobial drugs to shift communities
for multiple days post-treatment, suggesting a window in which S. aureus could
access the skin unencumbered by competing residents or antimicrobial drugs. As
alcohol was found to have relatively minor effects on skin bacterial residents, with
the exception of Staphylococcus spp., we first tested whether treatment with this
antiseptic could promote S. aureus association. Specifically, mice were treated with
alcohol, similarly to previous experiments, and then exogenously associated with S.
aureus one day post-treatment. As hypothesized, we observed a slight, but
significant, increase in S. aureus levels in treated mice compared to untreated
controls, indicating a reduction in colonization resistance in response to treatment
(Fig. 5a).
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Because this effect could also be the result of additional factors including previously
unidentified microbial inhabitants, we next profiled individual Staphylococcus
isolates that were reduced by antimicrobial treatment in our previous experiments.
We reasoned that if these bacteria were the true source of colonization resistance,
than adding them back to the skin should reduce S. aureus association in kind.
Following phenotypic analysis and full-length 16S rRNA gene sequencing, we
isolated five unique resident Staphylococcus genotypes – AS9, AS10, AS11, AS12, and
AS17. Comparing these to reference sequences within the Ribosomal Database
Project (RDP) (32), we identified four distinct species and two strain level variants:
S. epidermidis (AS9), S. xylosus (AS10, AS11), S. nepalensis (AS12), and S. lentus
(AS17) (Fig. 5b). Interestingly, while each of these bacteria fell within the
Staphylococcus genus, they also had considerable genomic variability within the 16S
rRNA gene region, suggesting a relative permissivity at the skin surface for these
particular taxa (Fig. S4).

To assess the colonization potential of each isolate, we next compared their growth
dynamics under various conditions. When comparing growth in enriched media, we
observed distinct differences amongst isolates, with AS17 S. lentus and AS10 S.
xylosus displaying the most robust expansion kinetics (Fig. 5b). By contrast, AS9 S.
epidermidis appeared to replicate the slowest and exhibited the most gradual
exponential curve. AS11 S. xylosus and AS12 S. nepalensis both displayed
intermediate growth patterns. To further evaluate colonization potential, we also
applied each Staphylococcus isolate to murine dorsa every other day for 1 week to
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promote monocolonization. Despite variable growth dynamics in vitro, all isolates
colonized mice to an equal titer in vivo, suggesting conserved, undefined factors to
promote colonization at the skin surface (Fig. 5c).

As each of these isolates displayed notable colonization when added to murine
hosts, we further tested all five to see whether they could also represent potential S.
aureus competitors. To evaluate the ability of each isolate to restrict S. aureus
colonization, we precolonized mice with each Staphylococcus resident prior to S.
aureus challenge one day later. While isolates exhibited varying levels of
competition, all resulted in significant decreases to S. aureus association compared
to uncolonized mice (Fig. 5d). Indeed most mice exhibited greater than 10-fold
reductions in S. aureus, and many, including those precolonized with S. epidermidis,
were capable of decreasing S. aureus by levels greater than 100-fold. In all, this
shows that skin bacterial residents can compete with S. aureus at the skin surface,
and that their removal can impact S. aureus colonization potential.

3.4 Discussion
Given the expansive use of topical antibiotics and antiseptics, it is somewhat
surprising that longitudinal studies to evaluate their effects on a community-wide
scale are not more common. Here we report that antimicrobial drugs can elicit
significant changes to skin bacterial community membership and structure, albeit to
varying degrees. We also demonstrate that these alterations can have important

87

consequences for colonization resistance and the skin pathogen Staphylococcus
aureus.

Previous work has focused extensively on antibiotics and the gut microbiota. These
studies have highlighted the ability of antimicrobials to disrupt bacterial
communities and the consequences of these drugs on host physiology (33). One
such example includes the elimination of colonization resistance leading to
increased susceptibility to bacterial infections (34). By altering the structure of
bacterial populations in the gut, antibiotics can shift the balance in favor of more
infectious microorganisms (19). Clostridium difficile is perhaps the best-studied
representation of this effect (35). However, additional pathogens such as
vancomycin-resistant Enterococcus and Salmonella enterica can also exploit newly
available niches and cause disease (36, 37). As a result, the true question has
transcended beyond whether or not antimicrobial drugs can promote pathogenicity,
to how best to mediate these unintended consequences.

The first step in such ventures is the elucidation of antimicrobial effects on a
community-wide scale. While studies of the gut have been vital to this endeavor, we
present the skin as an additional body site worthy of consideration. In our
investigations, triple antibiotic ointment (TAO) was found to provoke the greatest
response in microbial residence, with a significant decrease in bacterial diversity
and domination by previously minor contributors. While these changes originated
as a result of treatment-specific effects, they often endured, and in some cases were
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enhanced, following treatment cessation. This indicates that disrupted resident skin
bacteria must undergo multiple levels of succession prior to community
stabilization, similar to the gut (38).

In accordance with their mechanisms of action, we also found the overall effect of
mupirocin to be relatively minor compared to that of TAO. While TAO led to
profound increases in bacteria from multiple families including Enterobacteriaceae
and Porphyromonadaceae, mupirocin produced relatively minor shifts in less
abundant taxa such as Alistipes and Oscillibacter. This finding is particularly notable
as certain members of the Enterobacteriaceae and Porphyromonadaceae families
have known intrinsic resistance mechanisms against TAO components such as
polymyxin B (39, 40), a result that could also explain the increase in overall
bacterial load seen in mice following TAO administration.

Perhaps most surprisingly, we also report a relatively muted impact of antiseptics
on the skin microbiota, with alcohol and povidone-iodine both failing to shift
baseline communities in a significant manner. While it is tempting to explain this
finding as an inability of 16S rRNA gene sequencing to distinguish between live and
dead bacteria, we find this conclusion unlikely in the context of our studies and
those before us. Indeed, our ability to detect differences in TAO-treated mice within
one day of treatment provides strong evidence to the contrary. Others have also
reported a similar community response to both decolonization protocols (41) and
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mild and antibacterial soaps (42), confirming the stability of cutaneous populations
in response to certain acute stressors.

With this in mind, it is important to note that multiple studies have also shown a
reduction of certain culturable skin inhabitants in response to antisepsis. This
includes residents from the commonly studied genus Staphylococcus, often chosen
for its ease of use in culture-based experiments (43, 44). In line with these findings,
we also observed a decrease in Staphylococcus residents in our sequencing and
culture studies. However, we note that because this bacterium was only one
member of the larger community, this decline did not lead to shifts in overall
population structure.

Interestingly, Staphylococcus residents also exhibited baseline-dependent dynamics
in response to antiseptic treatment during our sequencing experiments. Specifically,
we observed that mice with high levels of Staphylococcus responded more readily to
treatment than mice with low levels of colonization. This suggested a nuanced
impact of antiseptics on certain bacterial inhabitants, whereby treatment effects
could vary depending upon starting communities. To verify this hypothesis, we
developed a system in which Staphylococcus could be tested for antimicrobial
susceptibility at both high and low colonization levels. As anticipated, we found the
efficacy of antiseptics to be highly dependent upon baseline communities. Mice with
low levels of Staphylococcus at baseline (LS) exhibited little to no decline in
Staphylococcus, while mice with high levels (HS) were reduced by approximately
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100-fold. Importantly, we observed a similar effect in control HS mice, suggesting
that higher levels of Staphylococcus are less stable in general, and thus represent
atypical colonization. By contrast, the inability of antiseptics to reduce
Staphylococcus in LS mice indicates a relative stability in this community, and a
population capable of resisting the short-term stressors of antisepsis. We believe
these studies have important implications for antimicrobial efficacy, particularly in
the case of human skin, as humans are likely exposed to a greater number of
transient microorganisms compared to laboratory mice housed in more controlled
environments (45).

When comparing antibiotic and antiseptic treatments, we observed that a standard
course of antibiotics was more capable of community disruption than that of acute
antisepsis. While these are the most commonly employed regimens in the clinic,
further research should also evaluate the effects of long-term antiseptic treatments
on the skin microbiota as well as other delivery mechanisms. Indeed the potential
exists that consistent exposure to antiseptics through alternative means may have a
more significant impact on skin inhabitants due to increased contact time or
bioavailability. This is especially important when considering the rise of
decolonization practices in the clinic, a procedure employing multiday, prophylactic
antibiotic and antiseptic treatments to remove resident Staphylococcus species (46,
47). While these methods efficiently remove endogenous S. aureus from the nares
and extranasal body sites, they likely alter the underlying skin microbiota in kind.
Without proper re-colonization, these interventions could feasibly elicit long-term
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shifts to the skin microbiota, similar to our experiments, and promote infection by
more dangerous hospital- and community-acquired pathogens (48-50).

To assess this very possibility, we investigated the potential of treatment to
promote S. aureus colonization at the skin surface in our mouse model. In response
to treatment, we observed a significant increase in S. aureus levels compared to
untreated controls following exogenous association, suggesting an increase in
cutaneous permissivity. As previous studies have illustrated the role of certain
Staphylococcus spp. to compete with S. aureus for colonization (27-29), we
proceeded by testing the ability of murine Staphylococcus isolates to compete with S.
aureus. Specifically, we chose Staphylococcus residents that were disrupted by
antibiotic and antiseptic treatment in our previous experiments for further analysis.
This allowed us to determine whether these particular bacterial residents were
responsible for the decrease in colonization resistance, and to confirm the ability of
antimicrobial drugs to alter communities with the potential for S. aureus
competition. Importantly, we found that all isolates were capable of protecting
against S. aureus association, with a number of mice exhibiting reductions in S.
aureus levels by over 100-fold. These results support the notion that antimicrobial
drugs can impact S. aureus colonization resistance, and argue for enhanced
stewardship in the context of post-treatment recovery.

In all, we describe the importance of antimicrobial drugs to skin bacterial
community dynamics. By detecting unique changes in the microbiota in response to

92

topical antibiotics and antiseptics, we present the skin as a body site capable of
reproducible disruptions and fluctuations in colonization resistance. For this reason
and others, we further advocate for the judicious use of antibiotics and antiseptics,
as well as increased monitoring of bacterial populations, in order to combat the
unintentional consequences which can proceed cutaneous perturbations.

3.5 Materials and Methods
3.5.1 Mice
Six-week-old female SKH-1 immunocompetent hairless mice were purchased from
Charles River and acclimated for at least two weeks prior to testing. Throughout
experimentation, mice were housed on ALPHA-Dri bedding and given ad libitum
access to autoclaved food and water. Mice treated with the same antimicrobial drug
or exogenous Staphylococcus strains were housed together to avoid mixing, and at
least two cages were used per condition to assess caging effects. All cages were
changed three to four times per week during the course of a study unless otherwise
noted. All mouse procedures were performed under protocols approved by the
University of Pennsylvania Institutional Animal Care and Use Committee.

3.5.2 Antimicrobial treatment
For experiments involving antibiotics, mice were treated on the dorsum with
mupirocin (2% in polyethylene glycol) or a triple antibiotic ointment (Bacitracin
400U, Neomycin 3.5mg, Polymyxin B 5,000U in petrolatum) every 12 hours for 7
days. To control for any vehicle-specific affects, the control ointments for each
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antibiotic were also used: polyethylene glycol (PEG 400, PEG 3350) and petrolatum.
For experiments involving antiseptics, mice were treated on the dorsum with
UltraPure water (MoBio), alcohol (80% ethanol), or povidone-iodine (Betadine,
10%) every eight hours, three times total. At least three cages of three mice each
were used for all conditions to evaluate caging effects.

3.5.3 Bacterial DNA isolation and 16S rRNA gene sequencing and qPCR
Cutaneous swabs were collected at baseline, during, and following treatment from
mouse dorsa and stored at −20 °C. Bacterial DNA was extracted as described
previously (51). Briefly, Ready-Lyse Lysozyme solution (Epicentre), bead beating,
and heat shock at 65 °C were used to lyse cells. The Invitrogen PureLink kit was
used for DNA extraction. During our testing, the V4 region of the 16S rRNA gene was
found to better approximate murine skin communities compared to V1V3. PCR and
sequencing of the V4 region was thus performed using 150-bp paired end chemistry
and barcoded primers (515F, 806R) on the Illumina MiSeq platform. Accuprime
High Fidelity Taq polymerase was used for PCR cycling conditions: 94 °C for 3 min;
followed by 35 cycles of 94 °C for 45 sec, 50 °C for 60 sec, 72 °C for 90 sec; and
ending with 72 °C for 10 min. For bacterial load comparisons, 16S rRNA genes were
amplified by qPCR using Fast SYBR Green Master Mix (Fisher Scientific) and the
optimized primers 533F, 902R. Samples were compared to standard curves
generated from known concentrations of serially diluted bacterial DNA to calculate
burden.
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3.5.4 Microbiome analysis
Sequencing data was processed using QIIME 1.7.0 (52). Briefly, sequences were de
novo clustered into OTUs based on 97% similarity by UClust (53), and taxonomy
was assigned to the most abundant representative sequence per cluster using the
RDP classifier (54). Sequences were aligned by PyNAST (55), and chimeric
sequences were removed using ChimeraSlayer (56) along with those identified as
Unclassified, Bacteria;Other, or Cyanobacteria. Singletons were also removed in
addition to any OTU found at greater than 1% abundance in at least 50% of control
samples to eliminate potential contaminating sequences. All antiseptics, antibiotics,
and vehicles were similarly sequenced and evaluated for possible contaminating
sequences. All samples were rarified to 5,000 sequences, and samples below this
cut-off were removed from downstream analyses. Alpha and beta diversity matrices
were calculated in QIIME, and statistical analysis and visualization were performed
in the R statistical computing environment (57). Heat maps were constructed by
condensing all OTUs above 0.1% to the top 30 taxonomic identifications. The
PICRUSt bioinformatics software package was used to infer functional content of
bacterial communities (31).

3.5.5 Caging effects
Mice were housed three per cage, three cages per group, and cages were randomly
assigned to be changed every other day (frequently) or once per week
(infrequently) for four weeks. Swabs were taken every seven days prior to changes
of the infrequent group, and cultured for Staphylococcus residents on Mannitol Salt
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Agar (acumedia) overnight at 37 °C. At d28, mice from each cohort were reassigned
to the alternate group, and swabbed for an additional four weeks to evaluate
normalization.

3.5.6 Antimicrobials and alternate Staphylococcus communities
Mice were assigned to frequent or infrequent cage changes prior to treatment to
generate low Staphylococcus and high Staphylococcus communities respectively, and
treated as described above. During experimentation, all cages were changed on a
frequent schedule with untreated mice representing controls. Swabs were taken at
baseline, d1, d4, and d7 for antibiotic-treated mice, and at baseline and 4 hours posttreatment for antiseptic-treated mice. Samples were cultured on MSA overnight at
37 °C to enumerate Staphylococcus numbers.

3.5.7 Staphylococcus isolation, sequencing, and phylogenetic tree
To obtain a more complete profile of our Staphylococcus isolates, phenotypically
distinct Staphylococcus colonies were picked from MSA plates following culture
from murine dorsa prior to and following antimicrobial treatment. DNA was
extracted from colonies as described above, and DNA was PCR-amplified using fulllength 16S rRNA gene primers (27F, 1492R). The primary PCR conditions used were
98 °C for 3 min; 35 cycles of 95 °C for 45 sec, 56 °C for 60 sec, 72 °C for 90 sec; and
72 °C for 10 min. Full-length 16S rRNA gene sequencing was performed by Sanger
sequencing, and resident Staphylococcus isolates were compared to known
Staphylococcus 16S rRNA genes downloaded from the RDP database (32).
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Phylogenetic trees were generated by FastTree (58) and visualized in FigTree
v1.4.3.

3.5.8 Growth curves
Staphylococcus isolates were grown at 37 °C in liquid Luria Broth (Fisher Scientific)
for 12 hours shaking at 300 rpm. Samples were taken every hour and optical density
was determined at OD600 using the BioTek Synergy HT plate reader.

3.5.9 Exogenous Staphylococcus colonization and S. aureus competition
Staphylococcus isolates were grown overnight in liquid Luria Broth (Fisher
Scientific) at 37 °C and 300rpm. On the following day, isolates were subcultured and
incubated to achieve log growth, and resuspended in PBS to acquire 108 CFU/ml
inoculums. Titers were validated by culture and optical density measurements at
OD600. Two cages of three mice each were monoassociated at the dorsum with 200ul
of Staphylococcus isolate inoculum using a sterile swab. Application of
Staphylococcus suspensions were repeated every other day over the course of one
week for a total of four applications. Mice were then swabbed one day postassociation, and cultured on MSA overnight at 37 °C for CFU enumeration. S. aureus
502A with selective streptomycin resistance was chosen for S. aureus competition
studies because of its proven efficiency in skin colonization and potential for
pathogenicity (59, 60). S. aureus was grown similarly to Staphylococcus isolates and
applied one day post-treatment or one day post-monoassociation with individual
Staphylococcus isolates. Control mice were administered PBS only. Mice were then
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swabbed the following day for S. aureus, and cultured on LB agar with streptomycin
for selective CFU enumeration.

3.6 Accession numbers
16S rRNA sequence reads have been deposited in the NCBI Short Read Archive
under BioProject ID: PRJNA383404
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Figure 1 Topical antibiotics induce long-term shifts to skin microbial residents. (a)
Heat map of rarified abundances for the 30 most common phylotypes on murine
skin in response to treatment with polyethylene glycol (PEG), mupirocin,
petrolatum, or triple antibiotic ointment (TAO). Dendrograms represent
hierarchical clustering of Euclidean distances using complete agglomeration.
Horizontal bars above the graph designate treatment and time point features for
individual mice. (b-d) Breakdown and longitudinal analysis of rarified abundances
for Enterobacteriaceae (b), Clostridiales (c), and Porphyromonadaceae (d). Data are
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presented as mean ± s.e.m. Statistical significance was determined at each time
point by Wilcoxon rank sum test (Mann Whitney U test). *P < 0.05, ** P < 0.01, *** P
< 0.001, **** P < 0.0001.
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Figure 2 Triple antibiotic ointment alters skin bacterial diversity. (a) Shannon
diversity measurements of murine bacterial communities following treatment with
antibiotics and vehicles over time. (b) Weighted UniFrac distances comparing
longitudinal time points to baseline communities of bacterial residents in treated
and untreated mice. (c) Principal coordinates analysis of weighted UniFrac distances
for murine bacterial communities over time. Data are presented as mean ± s.e.m.
Statistical significance was determined at each time point by Kruskal-Wallis rank
sum test (a) or Wilcoxon rank sum test (Mann Whitney U test) (b). *P < 0.05, ** P <
0.01, *** P < 0.001, **** P < 0.0001.
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Figure 3 Antiseptic treatment induces only minor changes to skin microbial
communities. (a) Heat map of rarified abundances for the 30 most common
phylotypes on murine skin following treatment with water, alcohol, or povidoneiodine. Dendrograms represent hierarchical clustering of Euclidean distances using
complete agglomeration. Horizontal bar above the graph designates treatment for
individual mice. (b) Shannon diversity of murine bacterial communities in response
to treatment. (c) Weighted UniFrac principle coordinates analysis representing
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differences in murine bacterial populations following treatment. (d) Bacterial load
comparison of treated and untreated mice calculated by 16S rRNA gene content at
the skin surface. Untreated (U), water (W), alcohol (A), povidone-iodine (P-I).
Treatments were compared by Kruskal-Wallis rank sum test (b, d) or the adonis
statistical test for community similarity (c).

103

a
8

Log Staphylococcus CFUs

***
***

****

***
****

***

***

***

6

Change Frequency
Group 1

4

Group 2

2

0
d0

d14

d21

d28
d35
Time Point

c

Log Staphylococcus CFUs

8

**
††

6

**
††

**
††

4

Treatment
No Treat
PEG
Mupirocin
Petrolatum
TAO

2

0

d42

d49

**
††
6

Treatment

††
††

No Treat
PEG
Mupirocin
Petrolatum
TAO

4

2

0
0

1

2

3

4

5

6

0

7

1

2

d

3

4

5

6

7

Day

Day

e

Post-TRX

Baseline

Post-TRX

Baseline
8

n.s.

n.s.

n.s.

Log Staphylococcus CFUs

8

Log Staphylococcus CFUs

d56

8

Log Staphylococcus CFUs

b

d7

n.s.

6

4

2

**

**

**

**

U

W

A

P-I

6

4

2

0

0
U

W

A

P-I

Treatment

Treatment

Figure 4 Antimicrobial treatment alters resident Staphylococcus colonization in a
baseline-dependent manner. (a) Murine resident Staphylococcus colony forming
units (CFUs) in response to cage change frequency over time. Group 1 mice were
changed every other day and Group 2 mice were changed once per week at the start.
Groups were switched to the alternate regimen at d28. Data are presented with
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median bars. (b, c) Murine resident Staphylococcus CFUs in response to antibiotic
treatment starting at low (b) or high (c) baseline levels. Statistical comparisons
were made between polyethylene glycol (PEG) and mupirocin (*) or petrolatum and
triple antibiotic ointment (TAO) (†). Data are presented as mean ± s.e.m. (d, e)
Murine resident Staphylococcus CFUs in response to antiseptic treatment starting at
low (d) or high (e) baseline levels. Untreated (U), water (W), alcohol (A), povidoneiodine (P-I). Statistical significance was determined by Wilcoxon rank-sum test
(Mann Whitney U test). *P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
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Figure 5 Resident Staphylococcus can reduce colonization by Staphylococcus aureus.
(a) Staphylococcus aureus colony forming units (CFUs) following exogenous
administration in mice pretreated with alcohol or untreated controls. (b)
Phylogenetic tree of 16S rRNA gene diversity using approximate-maximumlikelihood to compare murine Staphylococcus residents (red) to known
Staphylococcus isolates from the RDP database (black). (c) Growth curve analysis of
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resident Staphylococcus isolates at Optical Density 600 (OD600). (d) Enumeration of
Staphylococcus isolate CFUs following exogenous administration to mouse dorsum.
(e) S. aureus CFU levels following precolonization of mouse dorsum with resident
Staphylococcus isolates. Data are presented as mean ± s.e.m (a) or with median bars
(d, e). Statistical significance was determined by Wilcoxon rank-sum test (Mann
Whitney U test). *P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
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3.10 Supplemental Figures
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Supplemental Figure 1 Long-term alterations of select bacterial taxa in response to
topical antibiotic treatment. (a) Schematic diagram of antibiotic treatments and
sample collection regimen in mice administered polyethylene glycol (PEG),
mupirocin, petrolatum, or triple antibiotic ointment (TAO). Treatment cohorts
consisted of nine mice total, three cages of three mice each. Treatment occurred
every 12 hours for one week, and mice were followed for 4 weeks post-treatment.
(b,c) Longitudinal rarified abundances of (b) Staphylococcus and (c) Alistipes and
Oscillibacter. (d) Variations in bacterial burden over time in response to treatment.
Data are presented as mean ± s.e.m. Statistical significance was determined at each
time point by Wilcoxon rank sum test (Mann Whitney U test). *P < 0.05, ** P < 0.01,
*** P < 0.001, **** P < 0.0001.
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Supplemental Figure 2 Changes to functional potential of bacterial communities in
response to topical antibiotic treatment. Relative abundances of major KEGG
Pathways calculated by PICRUSt analysis of bacterial populations following one
week of treatment with polyethylene glycol (PEG), mupirocin, petrolatum, or triple
antibiotic ointment (TAO). Data are presented as mean ± s.e.m. Statistical
significance was determined for major pathway designations by Kruskal-Wallis rank
sum test and FDR correction. *P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.
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Supplemental Figure 3 Effects of antiseptics on skin bacterial inhabitants. (a)
Model of antiseptic treatments and sample collection in mice treated with water,
alcohol, or povidone-iodine. Treatment cohorts consisted of nine mice total, three
cages of three mice each. Mice received three treatments total, one every 8 hours,
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and were followed for one-week post treatment. (b) Rarified Staphylococcus
abundance in response to treatment over time.
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Supplemental Figure 4 Resident Staphylococcus isolate 16S rRNA gene sequences.
Comparison of Sanger sequenced murine resident Staphylococcus 16S rRNA genes.
Consensus sequence logo is notated above isolate sequences. Nucleotides with
greater than 50% conserved identity are depicted in blue. Non-conserved
nucleotides are unhighlighted.
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3.11 Supplemental Tables
Supplemental Table 1 Taxonomic comparisons of treatment groups at d1 posttreatment. Significances calculated with FDR-corrected Kruskal-Wallis tests.
Lineage

Actinobacteria; Actinobacteria; Actinomycetales; Microbacteriaceae

FDRcorrected
p-value
0.9263883

Actinobacteria; Actinobacteria; Actinomycetales; Micrococcaceae; Kocuria

0.6638857

Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae

0.6638857

Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae; Parabacteroides

0.4254647

Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; Chryseobacterium

0.6638857

Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; Elizabethkingia

0.6638857

Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae; Flavobacterium

0.6486878

Bacteroidetes; Sphingobacteria; Sphingobacteriales; Sphingobacteriaceae;
Sphingobacterium
Deferribacteres; Deferribacteres; Deferribacterales; Deferribacteraceae; Mucispirillum

0.1687431

Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Jeotgalicoccus

0.6638857

Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Staphylococcus

0.3879636

Firmicutes; Bacilli; Lactobacillales; Enterococcaceae; Enterococcus

0.3879636

Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae; Lactobacillus

0.6638857

Firmicutes; Bacilli; Lactobacillales; Leuconostocaceae; Weissella

0.6486878

Firmicutes; Clostridia; Clostridiales

0.6638857

Firmicutes; Clostridia; Clostridiales; Lachnospiraceae

0.6486878

Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Dorea

0.3827328

Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Johnsonella

0.649452

Firmicutes; Clostridia; Clostridiales; Ruminococcaceae

0.4254647

Firmicutes; Clostridia; Clostridiales; Ruminococcaceae; Oscillibacter

0.4254647

Firmicutes; Clostridia; Clostridiales; Veillonellaceae; Veillonella

0.6486878

Proteobacteria; Alphaproteobacteria; Sphingomonadales; Sphingomonadaceae;
Novosphingobium
Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae

0.1687431

Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae; Comamonas

0.6486878

Proteobacteria; Betaproteobacteria; Burkholderiales; Oxalobacteraceae; Massilia

0.8707155

Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae

0.7751558

Proteobacteria; Gammaproteobacteria; Pseudomonadales; Moraxellaceae; Acinetobacter

0.6638857

Proteobacteria; Gammaproteobacteria; Pseudomonadales; Pseudomonadaceae;
Pseudomonas
Proteobacteria; Gammaproteobacteria; Xanthomonadales; Xanthomonadaceae;
Stenotrophomonas
Tenericutes; Mollicutes; Anaeroplasmatales; Anaeroplasmataceae; Anaeroplasma

0.1687431
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0.395196

0.6486878

0.6486878
0.6486878

Supplemental Table 2 Taxonomic comparisons of lineages at d0 and d1 posttreatment. Significances calculated with FDR-corrected Wilcoxon rank sum tests.
Treatment

Lineage

Betadine
Betadine

Proteobacteria; Gammaproteobacteria; Pseudomonadales;
Pseudomonadaceae; Pseudomonas
Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae

Betadine

Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Staphylococcus

1

Betadine

Firmicutes; Clostridia; Clostridiales

1

Betadine

Firmicutes; Clostridia; Clostridiales; Lachnospiraceae

1

Betadine

Proteobacteria; Gammaproteobacteria; Xanthomonadales;
Xanthomonadaceae; Stenotrophomonas
Firmicutes; Bacilli; Lactobacillales; Enterococcaceae; Enterococcus

1

Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae;
Elizabethkingia
Proteobacteria; Gammaproteobacteria; Enterobacteriales;
Enterobacteriaceae
Firmicutes; Clostridia; Clostridiales; Ruminococcaceae

1

1

Betadine

Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae;
Parabacteroides
Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae;
Flavobacterium
Deferribacteres; Deferribacteres; Deferribacterales; Deferribacteraceae;
Mucispirillum
Bacteroidetes; Sphingobacteria; Sphingobacteriales; Sphingobacteriaceae;
Sphingobacterium
Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae;
Chryseobacterium
Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae;
Comamonas
Firmicutes; Clostridia; Clostridiales; Ruminococcaceae; Oscillibacter

Betadine

Firmicutes; Bacilli; Lactobacillales; Leuconostocaceae; Weissella

1

Betadine

Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae

1

Betadine

Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Jeotgalicoccus

NA

Betadine

1

Betadine

Proteobacteria; Alphaproteobacteria; Sphingomonadales;
Sphingomonadaceae; Novosphingobium
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Dorea

Betadine

Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae; Lactobacillus

1

Betadine

1

Betadine

Proteobacteria; Gammaproteobacteria; Pseudomonadales; Moraxellaceae;
Acinetobacter
Tenericutes; Mollicutes; Anaeroplasmatales; Anaeroplasmataceae;
Anaeroplasma
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Johnsonella

Betadine

Actinobacteria; Actinobacteria; Actinomycetales; Micrococcaceae; Kocuria

1

Betadine

Actinobacteria; Actinobacteria; Actinomycetales; Microbacteriaceae

1

Betadine

Firmicutes; Clostridia; Clostridiales; Veillonellaceae; Veillonella

1

Betadine
Betadine
Betadine
Betadine
Betadine
Betadine
Betadine
Betadine
Betadine
Betadine

Betadine
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FDRcorrected
p-value
1
1

1

1
1

1
1
1
1
1
1

1

1
1

Betadine

1

Ethanol

Proteobacteria; Betaproteobacteria; Burkholderiales; Oxalobacteraceae;
Massilia
Proteobacteria; Gammaproteobacteria; Pseudomonadales;
Pseudomonadaceae; Pseudomonas
Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae

Ethanol

Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Staphylococcus

0.019744961

Ethanol

Firmicutes; Clostridia; Clostridiales

1

Ethanol

Firmicutes; Clostridia; Clostridiales; Lachnospiraceae

1

Ethanol

Proteobacteria; Gammaproteobacteria; Xanthomonadales;
Xanthomonadaceae; Stenotrophomonas
Firmicutes; Bacilli; Lactobacillales; Enterococcaceae; Enterococcus

1

Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae;
Elizabethkingia
Proteobacteria; Gammaproteobacteria; Enterobacteriales;
Enterobacteriaceae
Firmicutes; Clostridia; Clostridiales; Ruminococcaceae

1

1

Ethanol

Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae;
Parabacteroides
Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae;
Flavobacterium
Deferribacteres; Deferribacteres; Deferribacterales; Deferribacteraceae;
Mucispirillum
Bacteroidetes; Sphingobacteria; Sphingobacteriales; Sphingobacteriaceae;
Sphingobacterium
Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae;
Chryseobacterium
Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae;
Comamonas
Firmicutes; Clostridia; Clostridiales; Ruminococcaceae; Oscillibacter

Ethanol

Firmicutes; Bacilli; Lactobacillales; Leuconostocaceae; Weissella

1

Ethanol

Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae

1

Ethanol

Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Jeotgalicoccus

1

Ethanol

1

Ethanol

Proteobacteria; Alphaproteobacteria; Sphingomonadales;
Sphingomonadaceae; Novosphingobium
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Dorea

Ethanol

Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae; Lactobacillus

1

Ethanol

1

Ethanol

Proteobacteria; Gammaproteobacteria; Pseudomonadales; Moraxellaceae;
Acinetobacter
Tenericutes; Mollicutes; Anaeroplasmatales; Anaeroplasmataceae;
Anaeroplasma
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Johnsonella

Ethanol

Actinobacteria; Actinobacteria; Actinomycetales; Micrococcaceae; Kocuria

1

Ethanol

Actinobacteria; Actinobacteria; Actinomycetales; Microbacteriaceae

1

Ethanol

Firmicutes; Clostridia; Clostridiales; Veillonellaceae; Veillonella

1

Ethanol

1

No Treat

Proteobacteria; Betaproteobacteria; Burkholderiales; Oxalobacteraceae;
Massilia
Proteobacteria; Gammaproteobacteria; Pseudomonadales;
Pseudomonadaceae; Pseudomonas
Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae

No Treat

Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Staphylococcus

0.148087207

Ethanol

Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol
Ethanol

Ethanol

No Treat
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1
1

1

1
1

1
1
1
1
1
1

1

1
1

0.932949404
1

No Treat

Firmicutes; Clostridia; Clostridiales

1

No Treat

Firmicutes; Clostridia; Clostridiales; Lachnospiraceae

1

No Treat

Proteobacteria; Gammaproteobacteria; Xanthomonadales;
Xanthomonadaceae; Stenotrophomonas
Firmicutes; Bacilli; Lactobacillales; Enterococcaceae; Enterococcus

1

Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae;
Elizabethkingia
Proteobacteria; Gammaproteobacteria; Enterobacteriales;
Enterobacteriaceae
Firmicutes; Clostridia; Clostridiales; Ruminococcaceae

1

1

No Treat

Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae;
Parabacteroides
Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae;
Flavobacterium
Deferribacteres; Deferribacteres; Deferribacterales; Deferribacteraceae;
Mucispirillum
Bacteroidetes; Sphingobacteria; Sphingobacteriales; Sphingobacteriaceae;
Sphingobacterium
Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae;
Chryseobacterium
Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae;
Comamonas
Firmicutes; Clostridia; Clostridiales; Ruminococcaceae; Oscillibacter

No Treat

Firmicutes; Bacilli; Lactobacillales; Leuconostocaceae; Weissella

1

No Treat

Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae

1

No Treat

Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Jeotgalicoccus

1

No Treat

0.070091195

No Treat

Proteobacteria; Alphaproteobacteria; Sphingomonadales;
Sphingomonadaceae; Novosphingobium
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Dorea

No Treat

Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae; Lactobacillus

1

No Treat

1

No Treat

Proteobacteria; Gammaproteobacteria; Pseudomonadales; Moraxellaceae;
Acinetobacter
Tenericutes; Mollicutes; Anaeroplasmatales; Anaeroplasmataceae;
Anaeroplasma
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Johnsonella

No Treat

Actinobacteria; Actinobacteria; Actinomycetales; Micrococcaceae; Kocuria

1

No Treat

Actinobacteria; Actinobacteria; Actinomycetales; Microbacteriaceae

1

No Treat

Firmicutes; Clostridia; Clostridiales; Veillonellaceae; Veillonella

1

No Treat

1

Water

Proteobacteria; Betaproteobacteria; Burkholderiales; Oxalobacteraceae;
Massilia
Proteobacteria; Gammaproteobacteria; Pseudomonadales;
Pseudomonadaceae; Pseudomonas
Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae

Water

Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Staphylococcus

0.22213081

Water

Firmicutes; Clostridia; Clostridiales

1

Water

Firmicutes; Clostridia; Clostridiales; Lachnospiraceae

1

Water

Proteobacteria; Gammaproteobacteria; Xanthomonadales;
Xanthomonadaceae; Stenotrophomonas
Firmicutes; Bacilli; Lactobacillales; Enterococcaceae; Enterococcus

1

No Treat
No Treat
No Treat
No Treat
No Treat
No Treat
No Treat
No Treat
No Treat
No Treat

No Treat

Water

Water
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1

1
1

1
1
0.388151273
1
0.289846607
1

1

1
1

1
1

1

Water

Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae;
Elizabethkingia
Proteobacteria; Gammaproteobacteria; Enterobacteriales;
Enterobacteriaceae
Firmicutes; Clostridia; Clostridiales; Ruminococcaceae

1

1

Water

Bacteroidetes; Bacteroidia; Bacteroidales; Porphyromonadaceae;
Parabacteroides
Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae;
Flavobacterium
Deferribacteres; Deferribacteres; Deferribacterales; Deferribacteraceae;
Mucispirillum
Bacteroidetes; Sphingobacteria; Sphingobacteriales; Sphingobacteriaceae;
Sphingobacterium
Bacteroidetes; Flavobacteria; Flavobacteriales; Flavobacteriaceae;
Chryseobacterium
Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae;
Comamonas
Firmicutes; Clostridia; Clostridiales; Ruminococcaceae; Oscillibacter

Water

Firmicutes; Bacilli; Lactobacillales; Leuconostocaceae; Weissella

1

Water

Proteobacteria; Betaproteobacteria; Burkholderiales; Comamonadaceae

1

Water

Firmicutes; Bacilli; Bacillales; Staphylococcaceae; Jeotgalicoccus

NA

Water

1

Water

Proteobacteria; Alphaproteobacteria; Sphingomonadales;
Sphingomonadaceae; Novosphingobium
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Dorea

Water

Firmicutes; Bacilli; Lactobacillales; Lactobacillaceae; Lactobacillus

1

Water

1

Water

Proteobacteria; Gammaproteobacteria; Pseudomonadales; Moraxellaceae;
Acinetobacter
Tenericutes; Mollicutes; Anaeroplasmatales; Anaeroplasmataceae;
Anaeroplasma
Firmicutes; Clostridia; Clostridiales; Lachnospiraceae; Johnsonella

Water

Actinobacteria; Actinobacteria; Actinomycetales; Micrococcaceae; Kocuria

1

Water

Actinobacteria; Actinobacteria; Actinomycetales; Microbacteriaceae

1

Water

Firmicutes; Clostridia; Clostridiales; Veillonellaceae; Veillonella

1

Water

Proteobacteria; Betaproteobacteria; Burkholderiales; Oxalobacteraceae;
Massilia

1

Water
Water
Water
Water
Water
Water
Water
Water

Water
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1
1

1
1
1
1
1
1

1

1
1
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Chapter 4 - Topical treatment interventions elicit personalized and
site-specific shifts in human skin bacterial communities

The contents of this chapter are prepared for submission with the authors:
SanMiguel AJ, Meisel JS, Horwinski J, Zheng Q, Bradley CW, Grice EA.

4.1 Abstract
The skin microbiome represents a significant contributor to cutaneous health and
disease. This includes its roles in immune tolerance and defense against pathogenic
microorganisms. Despite these critical functions, the impact of topical interventions
meant to disrupt these communities remains poorly understood. In this study, we
present the effects of three clinically-relevant antiseptics, alcohol, povidone-iodine
(Betadine), and chlorhexidine, on cutaneous bacterial populations. We illustrate a
proficiency of these treatments in altering skin bacterial communities, a result
which was highly dependent on interpersonal and body site-specific signatures. We
also show that the magnitude of this response can be influenced by both the identity
and relative abundances of bacterial inhabitants. By comparing the effects of
antiseptic regimens, we highlight the importance of antibacterial activity and
mechanical clearance to treatment disruption. We also demonstrate the potential
for pre-treatment communities to inform post-treatment response. In all, these
results further our understanding of treatment-derived perturbations to the skin
microbiota, and establish the ability of topical interventions to influence skin
bacterial dynamics.
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4.2 Introduction
Skin represents a unique habitat, colonized by an equally unique set of
microorganisms (1). Previous studies have analyzed these residents in-depth,
describing a stable community distinguished by both inter- and intrapersonal
differences (2, 3). This includes the skin’s ability to select for microbial residents at
distinct biogeographic regions, each representing a niche with selective pressures
that can influence cutaneous microbial inhabitance (4). A number of studies have
also tested the importance of these residents to human health, underscoring their
ability to educate the immune system and protect against pathogenic skin
microorganisms (5-8). Together, these studies have highlighted the importance of
the skin microbiota, and outlined its role in host cutaneous defense.

In light of these findings, it is important to note that humans are constantly working
to disrupt skin microbial communities in both clinical and non-clinical settings (912). While antimicrobial agents are largely employed to reduce infection by
pathogenic microorganisms (13-15), these treatments can also act on resident
cutaneous species (16-18). This is especially true for antiseptics, a group of
antimicrobial agents used specifically for their indiscriminate mechanisms of action
(19, 20). Antiseptics are a mainstay of modern medicine, but have also infiltrated
our daily lives in the form of gels, wipes, and sprays designed to sterilize host
cutaneous surfaces (21-23). As the significance of skin resident microorganisms
becomes increasingly apparent, assessing the impact of these treatments on the
colonization dynamics of skin inhabitance becomes of equal importance. Indeed, we
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and others have recently expounded the potential for altered skin bacterial
communities to impact colonization by Staphylococcus aureus, while additional
reports have identified their importance in cutaneous diseases such as atopic
dermatitis (24-26). These studies have highlighted the significance of skin microbial
residents, and necessitated further research into treatment-derived perturbations.

To expand our knowledge in this regard, we present the first study to date of
antiseptics on human skin bacterial populations using sequencing-based
approaches. We show that treatment elicits a significant impact on skin
communities that is both personalized and body site-specific. We also show that
certain microorganisms are more likely to be perturbed than others, with both
abundance and bacterial identity representing key predictors of this response. Upon
deeper analysis, water was found to elicit a similar shift in bacterial communities
compared to alcohol and povidone-iodine (Betadine), indicating a conserved effect
of these interventions based on mechanical disruption. By contrast, we observed a
minimal impact of chlorhexidine treatment on skin residents, an effect likely
influenced by the ability of this antiseptic to kill, but not necessarily remove,
bacterial markers. In all, these results further our understanding of bacterial
dynamics at the skin surface, and outline the potential for topical treatments to
disrupt skin bacterial residence.
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4.3 Results
Thirteen subjects, six females and seven males, were recruited to evaluate the
effects of antiseptics on the skin microbiome. Treatments were applied to the volar
forearm and the upper back to evaluate alternate skin microenvironments (dry and
sebaceous, respectively), and each subject received identical treatments to control
for interpersonal variability. Subjects received water and alcohol (80% ethanol) on
contralateral body sites during their first series of visits, and povidone-iodine
(Betadine) and chlorhexidine during their second series of visits. Swab specimens to
analyze the microbiota were collected at baseline, prior to treatment, and posttreatment for 72 hours to assess longitudinal dynamics. Treated body sites were
also accompanied by adjacent, untreated control sites, while visits were separated
by at least two weeks to allow for microbial equilibration. Specific treatment
topography, timing, and subject demographics are provided in Fig. S1a and Table S1.
In total, 71,167,526 16S rRNA gene reads (hypervariable regions 1-3) were
sequenced. Following quality control and filtering, the final study cohort
represented 1,456 samples rarified to an even depth of 4,500 sequences per sample.

4.3.1 Baseline characteristics of study cohort
To validate our methods, we started by characterizing the baseline communities of
our study cohort. As previously reported (2, 4), we identified a strong impact of
biogeography on the skin microbiota. Back communities were largely dominated by
Propionibacteriaceae and Staphylococcaceae (Fig. 1a). By contrast, forearm
communities were more permissive, hosting increased proportions of additional
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taxa such as Streptococcaceae and Corynebacteriaceae, amongst others. Reflecting
these community compositions, alpha diversity was significantly different between
body sites, with the forearm exhibiting increased Shannon diversity, observed
species, and equitability compared to the back (Fig. 1b). These metrics also
highlighted the importance of interpersonal variability, as data points showed
consistent grouping by individual when assessing diversity at both body sites. When
comparing these communities at the population-level, prominent clustering of
subjects and body sites was observed by both weighted and unweighted UniFrac
metrics (Fig. 1c). Comparisons of baseline communities also identified interpersonal
variability and site-specificity as the most significant contributors to variation,
followed by time and body symmetry respectively (Fig. S1b, c). In all, these results
confirm previous work, and highlight the unique nature of resident skin bacterial
communities.

4.3.2 Treatment elicits personalized shifts to skin bacterial community
structure
To begin our investigation of antiseptics and the skin microbiota, we compared
baseline resident populations to communities at 1hr post-treatment. Using weighted
UniFrac and principal coordinates analysis, we observed minimal clustering of
samples in response to treatment at the forearm and back, with none eliciting a
significant shift in bacterial population structure (Fig. 2a). Because interpersonal
differences were the strongest contributors to variability at baseline, and could thus
mask more subtle effects of our treatments, we also compared subjects’ post-
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treatment communities to their baseline controls. Using this method we detected a
significant effect of both water and alcohol at the forearm for at least 6 hours posttreatment, suggesting a personalized effect of these treatments on population
structure (Fig. 2b). Indeed, while both treatments caused a more robust shift than
that seen in adjacent controls, neither could promote bacterial communities to a
state outside that of the broader study cohort (Fig. 2c). Comparisons of Shannon
diversity and bacterial burden also confirmed these effects with alcohol eliciting
significant decreases in diversity, and both water and alcohol decreasing overall
bacterial load (Fig. S2a, b).

To determine the specific taxa responsible for this shift, we next focused our
analysis on the most abundant taxa seen at the forearm. Specifically,
Corynebacteriaceae, Propionibacteriaceae, Streptococcaceae, and
Staphylococcaceae were chosen, as they represented a mean relative abundance of
approximately 70% in baseline samples. Similar to community level analyses, most
taxa were not significantly altered despite consistent changes by these taxa in the
majority of subjects in our study cohort (Fig. 2d). Indeed, only Streptococcaceae was
significantly decreased in response to treatment at the forearm, although both
Propionibacteriaceae and Staphylococcaceae were also disrupted in nearly all
subjects. In all, these data suggest that certain treatments can elicit changes to skin
bacterial communities, but that this effect is often masked by interpersonal
variability.
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4.3.3 Treatment results in decreases to skin bacterial membership
We next investigated whether treatment could elicit more significant changes to
skin bacterial membership by unweighted metrics, which are agnostic to the relative
proportions of bacterial taxa. In contrast to weighted comparisons, these tests
revealed a prominent shift in bacterial communities following treatment at both the
forearm and back (Fig. 3a). Moreover, when comparing treated communities to their
baseline controls, both the back and forearm were significantly disrupted by water,
alcohol, and Betadine compared to adjacent controls (Fig. 3b). To evaluate the cause
of this shift, we analyzed the effect of treatment on the total number of observed
species. We found that changes to community membership were largely driven by a
decrease in bacterial richness, with water, alcohol, and Betadine all significantly
reducing the number of observed species compared to adjacent controls (Fig. S3a).

To further investigate these results, we also tested the effect of treatment on the
membership of individual bacterial families. We found that Corynebacteriaceae,
Incertae Sedis XI, Micrococcaceae, Staphylococcaceae, and Streptococcaceae were
the most prominently disrupted taxa at both the forearm and back (Fig. 3c, Fig. S3b).
Moreover, when comparing the richness of these taxa at treated and adjacent body
sites, we found that each of these families were significantly decreased at treated,
but not untreated, areas of the skin (Fig. 3d, Fig. S3c). Interestingly, this effect did
not extend to all highly abundant families, as Propionibacteriaceae remained largely
unchanged regardless of treatment or body site. This suggests that certain bacteria
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may be less susceptible than others when assessing treatment-derived alterations to
bacterial membership.

4.3.4 Chlorhexidine retains free bacterial DNA at the skin surface
During these initial tests, we were particularly struck by the inability of
chlorhexidine to elicit a significant shift in bacterial community membership or
structure. This was especially surprising given its proven efficacy against pathogenic
microorganisms in hospital settings (27). As chlorhexidine is known for its ability to
cause allergic and dermatologic irritation in a subset of individuals (28), we
wondered whether acute treatment could result in cutaneous changes that would
allow for better binding of free DNA from dead bacteria. This would then explain our
inability to detect changes in the skin microbiota following chlorhexidine
application. To test this hypothesis, we evaluated a subset of our subjects for
alterations in skin barrier function by transepidermal water loss (TEWL) in
response to treatment. We reasoned that if chlorhexidine were to alter the skin,
making it more likely to bind free DNA, we should observe an increase in TEWL
similar to that seen in patients with atopic dermatitis and other dermatologic
conditions (29, 30). Upon testing, however, we found no significant differences in
TEWL when comparing treatments to each other, or to baseline controls at 1hr and
6hr post-treatment (Fig. S4a). This suggests that acute treatment with chlorhexidine
does not uniquely alter the integrity of the skin barrier.
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Although we have previously shown that treatment with antibiotic ointment, a
particularly adherent substance, has a minimal effect on the retention of dead
bacterial DNA (24), we still wondered whether chemical properties inherent to
chlorhexidine could be responsible for its lack of observed effect. To evaluate this
question, we applied marker bacterial DNA to the skin of mouse dorsa, and tested its
persistence following treatment with water, alcohol, Betadine, or chlorhexidine.
Surprisingly, we observed a unique ability of chlorhexidine to retain free bacterial
DNA at the skin surface, with the total amount of marker bacterial DNA exceeding
that of other treatment regimens at 1hr post-treatment by over 10-fold on average
(Fig. S4a, b). To test whether this effect could persist for multiple hours posttreatment, we also evaluated the quantity of DNA at 6hr post-treatment. Similar to
1hr time points, we found that mice treated with chlorhexidine retained more DNA
at the skin surface compared to other regimens at this time point as well (Fig. S4c).
These experiments suggest that our inability to detect differences following
chlorhexidine treatment were likely due to a unique ability of this antiseptic to bind
bacterial DNA to the skin surface, and not necessarily a deficiency in antibacterial
activity.

4.3.5 Treatment elicits convergence at distinct community types in a sitespecific manner
Because distinct chemical properties of chlorhexidine could represent a
confounding factor in our experiments, we next focused our investigations on water,
alcohol, and Betadine treatments only. Specifically, we tested whether an

137

unsupervised approach to community analyses could identify a conserved microbial
signature in post-treatment populations. Dirichlet multinomial mixture (DMM)
modeling utilizes probability distributions to establish a prior of metacommunities
(31). Clusters can then be generated based on the similarity of a sample to a given
metacommunity. Using this approach, DMM models identified 8 distinct clusters at
the forearm, with individual subjects often being dominated by a single community
type (Fig. S5a, b). Despite these interpersonal differences, however, we observed a
prominent convergence at DMM cluster 1 in response to all treatments, an effect
that was not observed at adjacent body sites (Fig. 4a, Fig. S5c). DMM cluster 1 was
differentiated by decreased bacterial diversity, specifically richness (Fig. 4b),
confirming our finding that treatment can significantly disrupt bacterial
membership. This particular cluster also displayed fewer taxon-specific indications,
suggesting a normalization of bacterial residents in response to treatment (Fig. 4c).
In contrast to the forearm, back communities did not converge on a single
community type following treatment (Fig. S5d, e). However, we did observe a slight
increase in low diversity clusters in certain instances (Fig. S5f). In all, these data
verify that treatment can elicit reproducible changes to skin bacterial communities,
but also underscore the importance of body site to calculations of resident stability.

4.3.6 Highly abundant bacterial families are the greatest contributors to
treatment-derived changes in skin bacterial communities
Our initial analyses suggested that certain bacterial taxa were disrupted more
significantly than others, an effect which could lead to the increased frequency of

138

DMM cluster 1 we observed immediately post-treatment. To assess this hypothesis,
we next tested characteristics shown to influence variation in untreated settings. We
reasoned that the most variable taxa in the absence of treatment were also the most
likely to change in response to topical intervention. As previous analyses have
identified intermediately abundant taxa as the most susceptible to temporal
fluctuation (32), we started by assessing the baseline variance of these taxa in our
study cohort. Specifically, we compared the variance of bacterial residents at
adjacent, contralateral, and temporally-controlled body sites to their mean relative
abundances. Similar to previous data, we observed a distinct second-order, powerlaw relationship in skin bacterial residents, with intermediately abundant members
varying the most in untreated, baseline communities (Fig. S6a).

To test which taxa were specifically responsible for these shifts, we assessed
baseline variance at the family level for each subject at the forearm and back. We
found that Propionibacteriaceae, Streptococcaceae, Staphylococcaceae,
Corynebacteriaceae, Micrococcaceae, and Incertae Sedis XI constituted the most
variable groups in baseline communities (Fig. S6b, c). Interestingly, rather than
representing only intermediately abundant taxa, however, these families were often
the most abundant residents in our study cohort, and also the most likely to vary in
response to treatment. To investigate this discrepancy more directly, we again
compared the variance of baseline taxa to their mean relative abundances, but this
time we further controlled for both interindividual differences and body sitespecificity. While we had previously observed a second-order relationship when
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aggregating subjects and body sites, stratification resulted in a more nuanced effect,
with the variance of taxa frequently plateauing when plotted against their mean
relative abundances (Fig. 5a). Indeed, top taxonomic groups were often found to
exhibit both the greatest levels of variance and the greatest mean relative
abundances, especially in the case of Propionibacteriaceae. Together, these results
suggest that intermediately abundant skin bacteria are the most likely to fluctuate at
higher levels of comparison, but that predominant taxa are more variable when
assessing personalized biogeographic regions.

Following these analyses, we next tested whether taxonomic variation at baseline
could be used as an indicator of post-treatment effects. Specifically, we compared
the baseline variance of bacterial families to their mean response following water,
alcohol, and Betadine treatments. We found that the taxa most likely to vary in the
absence of treatment were indeed the most likely to be disrupted by topical
intervention, with decreases in the relative proportions of most taxa being offset by
increases in Propionibacteriaceae (Fig. 5b). Importantly, we also observed that
interpersonal variability was a strong contributor to this trend, as subjects with low
variation of a given bacterial family were also less likely to exhibit shifts by those
members following treatment. This trend was recapitulated when comparing the
mean relative abundances of taxa to their mean treatment response as well. Once
again, the greatest differences were observed within the Propionibacteriaceae
family, which was both the most abundant bacterial family and the most likely to
increase following treatment (Fig. 5c). In all, these results indicate that both
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abundance and variation in untreated controls can inform treatment-derived effects,
but that bacterial identity is also an important variable when measuring overall
community response.

4.3.7 Body site specificity informs fluctuations of the most abundant bacterial
taxa
During these analyses, we noted that, unlike other taxa, Propionibacteriaceae
increased in relative abundance following treatment of the back. We also found that
a subset of subjects exhibited similar dynamics when Staphylococcaceae was their
most abundant taxon. Because we observed a decrease in bacterial load following
treatment in our previous analyses, these increases in relative proportions were
unlikely to represent increases in absolute abundance. However, they did suggest a
personalized response in which the most abundant taxon per subject was also the
most likely to persist following treatment. To test this hypothesis, we compared the
levels of each subject’s most abundant taxon at baseline to its mean relative
abundance following water, alcohol, and Betadine treatment. We found that in all
cases but one, the most abundant taxon at the back increased in relative proportions
following treatment regardless of identity, indicating a distinct competitive
advantage (Fig. 5d). To assess whether this effect was specific to the back, we also
examined the most abundant residents at the forearm. Unlike the back, only three
subjects displayed taxa at this body site with greater than 50% relative abundance.
Despite these varying properties, however, we still observed an increase in the
relative proportions of Propionibacteriaceae in multiple subjects following
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treatment, although this effect was not absolute (Fig. 5e). Interestingly, this trend
did not extend to all skin residents, as Corynebacteriaceae, Staphylococcaceae, and
Streptococcocaceae all decreased in abundance at the forearm, regardless of status.
These results verify that abundance can be used to predict treatment effects, but
also highlight the importance of body site to these outcomes.

4.3.8 Lowly abundant members of predominant bacterial families are the
most likely to vary in response to treatment
Our previous investigations outlined the importance of abundance and bacterial
identity when assessing the effects of water and antiseptic stress. To build on this
finding, we further asked whether relative abundance could be used to predict the
fluctuations of all taxa, rather than just the most prevalent taxon per subject. Indeed,
the mere fact that certain bacterial families were found stably at the skin surface,
regardless of subject, suggested a degree of competitive advantage for a subset of
residents. To assess this hypothesis, we began by partitioning OTUs into highly or
lowly abundant groups based on an abundance threshold of 0.5% - a value chosen
from the inflection point of OTU counts at baseline (Fig. S7a). We then investigated
alterations to the membership of these bacteria in response to treatment. In all, we
observed a significant decrease in the number of lowly abundant OTUs following
treatment at both the forearm and back (Fig. 6a), an effect due in large part to
decreases in Corynebacteriaceae, Incertae Sedis XI, Staphylococcaceae, and
Streptococcaceae (Fig. 6b, c Fig. S7b, c). By contrast, when evaluating highly
abundant OTUs, only Streptococcaceae at the forearm and Corynebacteriaceae at
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the back were significantly reduced, a result which did not significantly decrease the
total number of highly abundant OTUs. Similar to previous results, we also observed
no significant differences in the membership of Propionibacteriaceae, regardless of
abundance or body site. These findings confirm that bacterial identity represents a
critical factor when evaluating skin resident stability, and underscores the
importance of abundance to predictions of treatment response.

4.4 Discussion
The skin microbiota has proven essential to numerous functions in cutaneous health
and disease (5-8). However, few studies have assessed our ability to disrupt these
communities, or their dynamics following antimicrobial stress. Herein, we present
the impact of topical antiseptics on human skin bacterial populations, and outline
the importance of key variables to overall community response.

When evaluating treatments at a comparative level, we found water, alcohol, and
Betadine to have similar effects on skin bacterial residents. Rather than highlighting
the antibacterial nature of alcohol and Betadine, these results appear to underscore
the generalized qualities of certain topical interventions, namely their ability to
reduce inhabitance by mechanical cleansing (19). This result has been particularly
well-established in culture-based systems. Here, reports have outlined the ability of
certain topical treatments to both kill, and remove, pathogenic microorganisms,
with each feature playing an important role in infection control (33, 34). Mild, nonantibacterial soaps are also used with the sole purpose of clearance, further
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emphasizing the importance of this mechanism to skin hygiene and community
disruption (35, 36).

Unlike alcohol and Betadine, chlorhexidine was found to elicit only minor shifts in
skin bacterial residence. Given the ability of this antiseptic to reduce infections in
clinical settings (37), this suggested that chlorhexidine might work in a unique
manner to kill, but not remove, bacterial markers from the skin surface. To test this
hypothesis, we applied free bacterial DNA to mouse dorsa, and treated with water,
alcohol, Betadine, and chlorhexidine. We found that chlorhexidine was uniquely
proficient at retaining bacterial DNA at the skin surface, with significantly greater
levels of DNA at both 1hr and 6hr post-treatment. Further research will be
necessary to elucidate the precise mechanism by which chlorhexidine achieves this
feat. However, it is interesting to note that chlorhexidine is a cationic molecule,
distinguished by an ability to bind the epidermal surface for multiple hours posttreatment (38). As such, the potential exists that this antiseptic may retain bacterial
DNA through a dual interaction with skin keratinocytes and the negatively charged
DNA backbone.

While no study to date has investigated the impact of antiseptics on the human skin
microbiota by sequencing, others have assessed the effects of hand-sanitizers and
soaps (39, 40). These studies have largely supported culture-based tests, outlining
the importance of conserved mechanisms to topical treatment response. For
example, a recent study by Zapka, et al. found that water and hand washing elicited
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similar alterations to the skin microbiota as alcohol-based hand sanitizers in most
tests (39). We have also observed similar findings in murine skin communities, with
water reducing levels of colonizing Staphylococcus in a similar manner to 80%
ethanol and Betadine (24). A recent comparison of mild and antibacterial soaps has
confirmed these results as well, showing minimal differences when comparing their
impact on the colonizing levels of S. epidermidis (40).

In addition to these findings, each of the abovementioned studies observed a
relatively minor impact of treatment on skin bacterial communities. Given these
results, it is perhaps unsurprising that we initially observed only modest differences
in response to antiseptic stress. Only after controlling for personalization and body
site-specificity could we observe the true impact of our treatment regimens. These
results are further underscored by our finding that treatment often elicited the
strongest effects in low-level inhabitants. Indeed, highly abundant species likely
exist at a given skin niche due to an ability to resist both host-derived and acute
external stressors. As the skin is often colonized by particular strains with temporal
stability for years at a time (32, 41), this outlines a system by which multiple taxa
can exist on the skin surface, but only a subset is uniquely adapted for long-term
colonization. These observations pair well with previous, culture-based analyses.
Here, highly abundant skin residents have been shown to persist in response to
various treatments while transient, low-level bacteria often represent a less stable
group of community inhabitants (42-44).
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In addition to abundance, we also found that bacterial identity could influence
treatment response, with lowly abundant species from top taxa often being more
significantly disrupted than other skin residents. This finding underscores the
ecological advantages seen in bacterial families such as Propionibacteriaceae,
Staphylococcocaceae, Streptococcaceae, and Corynebacteriaceae. The prevalence of
these taxa at baseline in most subjects highlights their ability to utilize conserved
resources at and within the skin surface (45). Upon the introduction of treatmentderived stressors, however, a generalized selective advantage is no longer enough,
leading to the persistence of only the most resilient and well-adapted members of
each group.

Treatment-derived alterations were also observed to be dependent upon body site,
with the back representing a more stable habitat than the forearm. However, when
assessing the richness of predominant bacterial families, the back and forearm were
both found to be susceptible to a loss of lowly abundant OTUs. This finding
emphasizes the reproducibility of disruption in low level inhabitants, and illustrates
the conservation of certain outcomes at distinct biogeographic regions.
Interestingly, this result did not extend to all major taxa, as members of the
Propionibacteriaceae family persisted regardless of body site. We believe this
particular effect could be due to an inherent resilience of Propionibacteriaceae, or
an increased abundance at deeper, newly exposed layers of the skin. Regardless, the
persistence of this taxon likely represents a unique opportunity to thrive in the
post-treatment setting.
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In all, this study furthers our understanding of skin bacterial dynamics and
elucidates the effect of topical treatments on cutaneous resident populations. While
we observed a similar impact of water and certain antiseptics, we note that our
studies were designed to assess the totality of skin residents in healthy individuals.
As such, we caution against the application of these findings to clinical settings in
which the dynamics of pathogen and commensal are highly skewed. Indeed,
previous studies have described, in-depth, the utility of antiseptics in these
particular environments (46-48). As our study assesses only the effect of acute
stressors, we also advocate for further research into long-term treatment regimens.
The potential exists that more lasting perturbations may elicit even greater shifts to
skin bacterial communities, an important consideration when evaluating the nexus
of host-microbial interactions.

4.5 Materials and Methods
4.5.1 Human subjects and sample collection. Thirteen healthy subjects aged 2330 (median:27, 6 females) and without chronic skin disorders were recruited to
participate in a controlled skin antiseptic study (Table S1). To be eligible for
participation, subjects were required to be greater than 21 years of age, and could
not have taken oral or topical antibiotics within 6 months of their first visit. Subjects
were swabbed at baseline and then administered one of four treatments for 1.5
minutes. Each participant received water (UltraPure Distilled Water, Invitrogen)
and alcohol (80% ethanol) on contralateral forearm or back body sites during their
first visit series, and povidone-iodine (Betadine, 10% povidone-iodine)) and
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chlorhexidine (chlorhexidine-gluconate 4%) during their second visit series (Fig.
S1a). Visit series were separated by at least two weeks to allow for microbial
equilibration. Following treatment, subjects were swabbed at 1hr, 6hr, 12hr, 24hr,
36hr, and 72hr post-treatment at both treated and adjacent body sites. Swabbed
regions were delineated by a skin marker to ensure that the same body site was
swabbed at longitudinal time points. Subjects were instructed to refrain from
showering for at least 12 hours prior to each time point. Protocols were approved
by the Institutional Review Board of the University of Pennsylvania, and written
informed consent was obtained for all study participants prior to sampling.

4.5.2 Transepidermal water loss. Transepidermal water loss was measured in a
subset of four subjects using a Tewameter TM300 (Courage+Khazaka, Cologne,
Germany) according to the manufacturer’s instructions. Briefly, subjects were
equilibrated for at least 10 minutes prior to testing. Noninvasive probes were then
pressed to the skin at baseline, 1hr, and 6hr post-treatment with water, alcohol,
Betadine, or chlorhexidine to measure changes in skin epidermal barrier function.
Each process was repeated at both the forearm and back to assess differences by
body site.

4.5.3 Bacterial DNA isolation, 16S rRNA gene sequencing, and qPCR. Bacterial
DNA was extracted as described previously (49) using the Invitrogen PureLink kit.
PCR and sequencing of the V1V3 hypervariable region was performed using 300-bp
paired end chemistry and barcoded primers (27F, 534R) on the Illumina MiSeq
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platform. Accuprime High Fidelity Taq polymerase was used for PCR cycling
conditions: 94 °C for 3 min; 35 cycles of 94 °C for 45 sec, 50 °C for 60 sec, 72 °C for
90 sec; 72 °C for 10 min. For bacterial load comparisons, 16S rRNA genes were
amplified by qPCR using Fast SYBR Green Master Mix (Fisher Scientific) and the
optimized primers 533F, 902R. Samples were compared to standard curves
generated from known concentrations of serially diluted bacterial DNA to calculate
burden.

4.5.4 Microbiome analysis. Sequences were preprocessed and quality filtered
prior to analysis, and QIIME 1.7.0 was used for microbiome evaluation (50). Briefly,
sequences were de novo clustered into OTUs based on 97% similarity by UClust
(51), and taxonomy was assigned to the most abundant representative sequence per
cluster using the RDP classifier (52). Sequences were aligned by PyNAST (53), and
chimeric sequences were removed using ChimeraSlayer (54). Sequences with calls
to Unclassified, Bacteria;Other, or Cyanobacteria were removed in addition to
singletons. Antiseptics and negative controls were similarly sequenced and analyzed
for possible contaminating sequences, with no OTUs being found at consistently
high levels. All samples were rarified to 4,500 sequences, and samples below this
cut-off were removed from downstream analyses. Alpha and beta diversity matrices
and taxonomy tables were formulated in QIIME. Statistical analysis and visualization
were performed in the R statistical computing environment (55).
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4.5.5 Dirichlet multinomial mixture models. Subsampled OTU counts were
aggregated at the highest level of taxonomic classification. Samples were separated
by body site and spurious taxa in less than 1% of samples were removed. Clusters
were generated separately on forearm and back samples using the R package
Dirichlet Multinomial (v1.14.0), and community types for each body site were
calculated based on absolute minima from Dirichlet components and Laplace
approximations of model evidence (31). Samples were assigned to final community
types based on posterior probabilities.

4.5.6 DNA retention. C57BL/6 mice were bred and maintained in specific pathogen
free conditions at the University of Pennsylvania. Eight to fifteen week old males
and females were randomized to control for differences in age and gender, and each
mouse was housed singly to avoid cross-contamination. Mice were shaved at the
dorsum and acclimated for at least 2 days prior to experimentation. 5-6 ng/ul of
extracted Escherichia coli DNA was applied to mouse dorsa and permitted to dry for
1hr prior to treatment. Mice were then administered water, alcohol, Betadine, or
chlorhexidine for 1.5 minutes, similar to human experiments, and swabbed at 1hr
and 6hr post-treatment. Following sample collection, DNA was extracted using the
Invitrogen PureLink kit, and E. coli-specific DNA was amplified using qPCR primers
to the ycct gene (56). Samples were compared to standard curves generated from
known amounts of serially diluted E. coli DNA to calculate marker DNA
concentrations.
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4.6 Accession Numbers
16S rRNA sequence reads have been deposited in the NCBI Short Read Archive
under BioProject ID: XXXXXXXXXXX
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Figure 1 Skin bacterial communities exhibit site-specificity and interpersonal
variability at baseline. (a) Family-level relative abundances of baseline communities
for subjects at the forearm and back. Each bar represents an individual sample with
eight samples per subject based on controls at adjacent and contralateral body sites
for each visit series. (b) Alpha diversity of baseline communities at the forearm and
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back. Shannon diversity, observed species, and equitability are illustrated
separately. Each point is colored by subject. (c) Weighted (left) and unweighted
(right) UniFrac principal coordinates analyses of baseline samples. Each point is
colored by subject and shaped by body site. **** P < 0.0001 by Wilcoxon rank sum
test (Mann-Whitney U test).
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Figure 2 Treatment elicits personalized shifts in weighted comparisons of skin
bacterial populations. (a) Principal coordinates analysis of weighted UniFrac
distances for treated body sites at baseline and 1hr post-treatment. Each point
represents a single sample, colored by treatment and shaped by body site. (b)
Weighted UniFrac distances of subjects’ longitudinal time points compared to their
individual baseline communities at treated and adjacent body sites. Points represent
the median of participants. Error bars designate interquartile regions. (c)
Subanalysis of weighted UniFrac distances visualized by principal coordinates
analysis in subjects treated with water and alcohol at the forearm. Lines connect
baseline and 1hr post-treatment samples for individual subjects, and line types
designate treatment regimen. Line colors refer to treated body sites or their
respective adjacent controls. (d) Comparison of relative abundances for the top 4
taxa at baseline and 1hr post-treatment with water or alcohol. Each line represents
an individual subject colored by an increase or decrease in relative abundance
following treatment. * P < 0.05, ** P < 0.01 by Wilcoxon rank sum test (MannWhitney U test).
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Figure 3 Treatment results in distinct alterations to skin bacterial residents by
unweighted metrics. (a) Visualization of unweighted UniFrac distances by principal
coordinates analysis for treated body sites at baseline and 1hr post-treatment. Each
point represents a single sample, colored by treatment and shaped by body site. (b)
Comparison of unweighted UniFrac distances for baseline and post-treatment
communities in response to treatment at the forearm and back. Points represent the
median of participants. Error bars designate interquartile regions. (c) Difference
between OTU counts for the top 25 families at the forearm for baseline and 1hr
post-treatment samples in response to water, alcohol, and Betadine treatment.
Points represent the median of participants and are colored by scaled differences in
total count. Error bars designate interquartile regions. (d) Box and whisker plots of
OTU counts for major taxa at adjacent and treated body sites of the forearm
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between baseline and 1hr time points. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P <
0.0001 by Wilcoxon rank sum test (Mann-Whitney U test).
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mean ± s.e.m. (c) Heat map of square root counts for the top bacterial taxa
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Figure 5 Baseline variance and abundance are indicators of treatment-derived
alterations to the skin microbiota. (a) Family-level comparison of the baseline
variances (standard deviation) and mean relative abundances for subjects at the
forearm and back. Each point represents the values for bacterial families of an
individual subject, shaped by body site and colored by family. Lines connect families
of an individual subject and body site. “Other” designations refer to any bacterial
family different from the listed members (b) Baseline variance of bacterial families
plotted against their mean treatment effect in response to water, alcohol, and
Betadine treatment at the forearm and back. (c) Mean relative abundance of
bacterial families at baseline compared to mean treatment effects at the forearm
and back. (D, E) Mean difference in relative abundance of the most dominant taxon
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per subject following treatment at the back (d) and forearm (e). Each point
represents a single subject colored by bacterial family identity.
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Figure 6 Lowly abundant members of prominent taxa are the greatest contributors
to treatment effects at the skin surface. (a) Box and whisker plots of lowly and
highly abundant OTU counts as defined by a 0.5% relative abundance threshold
following treatment at the forearm and back. (b) Heat map of differences in forearm
OTU counts between baseline and 1hr post treatment with water and antiseptics.
Each column represents the difference measured for a single subject and treatment,
and each row represents a bacterial family. Samples are clustered by the
Unweighted Pair Group Method with Arithmetic means (UPGMA). Color-coded bars
above the graph designate treatments for each sample. (c) Comparison of lowly and
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highly abundant OTU counts at the forearm in major taxonomic families at baseline
and 1hr post-treatment. Points represent the median of the study cohort. Error bars
designate interquartile regions. * P < 0.05, ** P < 0.01, *** P < 0.001 by Wilcoxon
rank sum test (Mann-Whitney U test).
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4.10 Supplemental figures
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Supplemental Figure 1 Treatment regimen details and baseline community
comparisons. (a) Diagram of sampling and treatment schedule for antiseptic study
cohort. (b, c) Heat map of significances for weighted (b) and unweighted (c) UniFrac
comparisons at the forearm and back for interpersonal, adjacent, contralateral,
short-term (1hr), and long-term (visit) baseline community samplings.
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Supplemental Figure 2 Alpha diversity and bacterial load are decreased in
response to certain treatment regimens. (a) Longitudinal comparisons of Shannon
diversity for bacterial communities at adjacent and treated body sites of the back
and forearm. (b) Bacterial load at the forearm and back for treated and adjacent
body sites over time. Data is presented by median points and interquartile regions. *
P < 0.05, ** P < 0.01 by Wilcoxon rank sum test (Mann-Whitney U test).
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Supplemental Figure 3 Treatment elicits decreases in bacterial richness. (a)
Longitudinal measurements of observed species for adjacent and treated body sites
at the back and forearm. Data is presented by median points and interquartile
regions. (b) Difference between OTU counts for the top 25 families at the back for
baseline and 1hr post-treatment samples in response to water, alcohol, and
Betadine treatment. Points represent the median of participants and are colored by
the scaled difference in total count. Error bars designate interquartile regions. (c)
Box and whisker plots of OTU richness at the back for major taxa at adjacent and
treated body sites between baseline and 1hr time points. * P < 0.05, ** P < 0.01, *** P
< 0.001 by Wilcoxon rank sum test (Mann-Whitney U test).
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clusters at the back for adjacent and treated body sites. (f) Shannon diversity and
observed species counts of individual DMM clusters at the back. Data are presented
as mean ± s.e.m.
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points and interquartile regions. * P < 0.05, ** P < 0.01, *** P < 0.001 by Wilcoxon
rank sum test (Mann-Whitney U test).
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Chapter 5 - Conclusions and future directions

5.1 Conclusions and future directions
The results presented herein outline the impact of topical antimicrobial treatments
on skin bacterial inhabitance. In our experience, a number of conflicting opinions
exist in regard to skin bacterial dynamics. For example, it is not uncommon to
question a group of researchers and find that some believe the skin microbiota
exists as a stable resident community, while others assert its vulnerability to even
minor perturbations. As is often the case in scientific endeavors, it appears as
though the truth is likely complicated by circumstance, with neither view
representing an adequate means to describe the intricacies of our cutaneous
cohabitants.

In support of this concept, we found antiseptics to elicit varying effects in skin
bacterial residence. When assessing the impact of treatment on human subjects, we
observed a reproducible decrease in lowly abundant bacteria. By contrast, highly
abundant residents remained relatively stable over time. As highly abundant
residents comprised the majority of cutaneous populations, community structure
was largely preserved in response to treatment. However, changes to lowly
abundant residents did represent the opportunity to identify personalized
alterations in residence, shifts which were largely dependent on baseline
populations. This result was also seen in murine studies in which housing
conditions could influence baseline Staphylococcus levels, and the subsequent
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magnitude of antimicrobial response. We did not observe a significant reduction in
lowly abundant residents in these particular experiments, however, an effect we
hypothesize may be due to mice being housed in clean environments with reduced
exposure to transient bacteria.

The ability of highly abundant residents to resist acute antiseptic stress is perhaps
not altogether surprising. Indeed, when considering the dynamics of a community, it
appears most likely that highly abundant taxa have attained this status by more than
mere coincidence. Our results suggest that highly abundant bacteria represent a
group of inhabitants uniquely adapted to an individual, while lowly abundant
bacteria are more akin to transient passengers with a reduced capacity for
persistence. If true, acute treatment-derived alterations may enable researchers to
better interrogate host-microbial relationships, as they represent an opportunity to
distinguish between long and short-term inhabitance.

We find this proposition particularly attractive given the observation that certain
taxonomic groups were more easily disrupted than others in our studies, specifically
lowly abundant residents of top bacterial families. This points to the potential of the
skin to select for specific classes of bacteria, while only the most well-adapted of
each group may colonize stably over time. Indeed, without the competitive
advantages of highly abundant taxa, lowly abundant residents are likely ill-equipped
to survive most perturbations, resulting in their decreased residence in the posttreatment setting.
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With this in mind, our investigations educe two important questions. First, why
some taxonomic families are better equipped than others to withstand acute
stressors? And second, why certain members of these families are more capable of
long-term colonization than others? The answer to each question is likely the result
of both host- and microbial-derived features, with each contributing an important
role in skin bacterial residence.

We present Propionibacterium as a particularly salient example in this regard. As a
lipophilic member of the skin microbiota, these residents thrive on the oily
secretions produced by human sebaceous glands1. This, paired with their anaerobic
preferences, results in a distinct localization of Propionibacterium to cutaneous
structures with low levels of oxygen and high sebaceous gland activity2. During our
experiments, both highly and lowly abundant members of this genus were capable
of resisting treatment-derived alterations, leading to the possibility that
Propionibacterium may be uniquely adapted to resist antibacterial perturbation.
However, we find it equally likely that simply shielding themselves within
cutaneous appendages could also contribute to this resident’s overall stability.

With this in mind, we further note that Propionibacterium acnes strains have shown
a wide array of stratification throughout the human population3. Traditionally
thought of as the causative agent in acne vulgaris, certain strains of P. acnes are
considered to be more pathogenic than others4. Certain individuals are colonized by
these strains more readily than others as well5. This suggests that hosts play an
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important role in the selection of their P. acnes strains, with each clone exhibiting
unique competitive advantages over non-resident strains. Despite myriad
treatments to combat this bacterium and reduce the overall number of P. acnes
inhabitants, acne vulgaris remains a prevalent disorder in the developed world6.
Based on our experiments, we would hypothesize that P. acnes clones may persist
due to a unique ability to withstand acute interventions, and that certain treatments
may even exacerbate this condition if they present resilient P. acnes strains with
newly accessible niches.

Similar dynamics can also be seen with the skin pathogen Staphylococcus aureus. As
the most prominent cause of skin and soft tissue infections, S. aureus can establish
long-term residence in a subset of individuals7,8. Host-specific strains can then cause
a number of complications during surgery or other unplanned breaches of the skin9.
To combat this effect, decolonization strategies have been advanced as a means to
eliminate inhabitant S. aureus10. However, many of these studies have illustrated no
significant reductions in overall infection11. We believe this phenomenon may occur
as the result of S. aureus colonization’s dual nature in a host, with the ability to both
precipitate infection while simultaneously protecting against it depending upon the
circumstance.

To support this hypothesis, we note that while decolonization can reduce S. aureus
inhabitance, subsequent surgical infections can be accompanied by more severe
complications12. This happens as the result of infection by non-resident S. aureus, a
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result we propose may occur because of a loss in colonization resistance. Generally,
bacterial infections within a hospital setting are caused by microorganisms with
greater levels of resistance and increased virulence13,14. As such, the removal of
colonizing S. aureus acquired in the community-setting could explain infection by
these more harmful, hospital-associated pathogens.

This principle has been well-established in the gastrointestinal tract. Here,
Clostridium difficile, vancomycin-resistant Enterococcus, and Salmonella enterica are
all capable of causing disease with increased frequency following antibiotic
intervention15. Moreover, in the case of C. difficile, the administration of fecal
material with potentially protective bacteria can lead to a resolution of disease16.
These results indicate that antimicrobial treatment in the gut can reduce resident
competition in a host, and increase susceptibility to infection and disease.

To test the importance of this mechanism at the skin surface, we treated mice with
antimicrobial drugs and assessed their impact on the skin microbiota. We observed
a number of alterations in skin resident populations, including a conserved decrease
in Staphylococcus membership regardless of treatment. As these experiments
included the culture of pre- and post-treatment communities, we were able to
identify the specific Staphylococcus residents disrupted by treatment. We could then
pre-colonize mice with these same residents to evaluate their potential to compete
with S. aureus at the skin surface. As hypothesized, each resident was found to
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reduce association with S. aureus, underscoring the potential for the skin microbiota
to exhibit colonization resistance features.

While others have illustrated a similar ability of skin residents to compete with S.
aureus17,18, our study represents the first to establish the role of antimicrobial drugs
in this process. These results support the notion that a reduction in resident S.
aureus may impact colonization resistance and infection in human patients as well.
Further research is necessary to more completely evaluate this hypothesis,
however. This includes an investigation of additional factors that can influence S.
aureus residence, as well as studies outlining the importance of the human
microbiota in this process.

Because our studies only assess the impact of antimicrobial drugs on healthy skin, in
the absence of infection or wounding, additional research should also examine the
influence of these variables as they pertain to colonization resistance. The utility of
antibiotics and antiseptics to improve patient outcomes has been expounded atlength in these particular environments. However, little information exists in regard
to the susceptibility of patients to infection in the post-treatment setting. Our work
suggests that a window of susceptibility may exist during this time due to an
inability of communities to re-stabilize for multiple weeks post-treatment. If this
period includes impaired recolonization by protective skin residents, the potential
exists that antimicrobial treatments could promote infection by new pathogens as
well as recurrent strains.
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Fortunately, the skin represents a body site with unique advantages to study these
principles, namely an ability to apply competing residents directly to a site of
interest. While less harmful bacteria can be taken orally to compete against
pathogenic inhabitants of the gut, there is no guarantee that these bacteria will be
able to access a particular niche. Indeed, many experiments have outlined the
difficulties encountered by exogenously administered bacteria when attempting to
establish long-term colonization of the gut19-21. As colonization is the first step in the
majority of interference pathways, a deficiency at this stage understandably
complicates the study of bacterial competition.

Unlike the gut, skin represents an easy to access biological surface for colonization
resistance studies. Indeed, one can apply varying concentrations of bacteria directly
to the skin surface, and shift the equilibrium amongst any number of bacterial
inhabitants. We provide one such example of these advantages in our own
experiments. However, one could imagine the utility of these approaches when
testing additional skin residents and pathogens for competition and colonization
potential. We suggest that future experiments employ these methods to further
establish the mechanisms behind our particular findings, and extend these
observations to additional models.

Finally, we note that antimicrobial treatments varied in their ability to alter skin
bacterial residence. As previously mentioned, the antiseptics alcohol and povidoneiodine elicited relatively minor changes to bacterial population structure. Antibiotic
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treatment, by contrast, resulted in disruptions that were both immediate and
durable, with triple antibiotic ointment (TAO) shifting communities for multiple
weeks post-treatment. TAO treatment also led to the outgrowth of previously minor
contributors, underscoring the potential for alternative community states to
predominate following antibiotic treatment.

These results represent a number of opportunities for future investigation, with a
subset mentioned herein. First, we recognize that antibiotic effects were largely
agent-dependent, with TAO eliciting a more significant response than Mupirocin.
This suggests that broad spectrum antibiotics have a greater impact on skin
bacterial communities than those which target specific bacterial taxa. While this is
to be expected, subsequent work should also explore the ramifications of narrow
spectrum antibiotics that target more abundant skin residents. Indeed, the bacterial
genera most disrupted by Mupirocin, Staphylococcus and Streptococcus, were found
at relatively low levels in appropriately housed mice. As such, their removal would
not necessarily be expected to result in large shifts to overall community structure.

Second, we note that our antibiotic studies were performed only in murine hosts.
Consequently, the impact of antibiotics on human skin residents remains largely
unknown. If these drugs are capable of disrupting the human skin microbiota in a
similar manner to mice, this could have a number of important implications for host
cutaneous biology. Studies at alternate body sites have previously expounded the
importance of bacterial residents to immune function and development22. Future
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investigations should thus employ measurements of host gene expression and
immune cell populations, in order to more completely characterize the
consequences of skin bacterial perturbation.

Third, because our experiments focused on topical antimicrobial treatments, the
impact of oral antibiotics remains largely unknown. While oral antibiotics have the
potential to disrupt both gut and skin communities, no study to date has rigorously
explored the interplay between these systems. This would be especially compelling
in the case of antibiotics available in both oral and topical formulations. Indeed, the
potential exists that different routes of administration could have important
implications for skin and gut bacterial inhabitance alike.

As a final note, we recognize that our studies were performed using 16S rRNA gene
sequencing for bacterial identification. While this was necessary to maximize the
breadth of our comparisons, our studies have now outlined the optimal parameters
for these types of analyses. Future work can thus build upon these findings by
employing whole metagenome shotgun sequencing as a means to evaluate the
effects of antimicrobial drugs on the functional potential of skin communities, and
with strain-level resolution. These investigations will also be useful in determining
the impact of antibiotics and antiseptics on non-bacterial residents. Indeed, while
we have largely framed the question of antimicrobial effects as a “simple” matter of
bacterial dynamics, fungal and viral populations are undoubtedly affected in kind.
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In all, our studies outline the potential for antibiotics and antiseptics to alter skin
bacterial residence. However, future research will be essential to a more complete
understanding of this response. Our data underscore the potential for said
endeavors to inform unique mechanisms of cutaneous health and disease, and it is
our hope that studies such as these will result in a more prudent approach to
antimicrobial use in clinical settings and beyond.
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